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ABSTRACT 
 
Background: Few studies have evaluated habitual nutrient intake among HIV-infected 
youth in the United States, even though diet may influence immune function and thus 
HIV-related outcomes. This study sought to determine micro- and macronutrient intake in 
HIV-infected youth, and investigate the relationships among nutrient intake, 
demographics, lipid profiles, and HIV-related factors.  
 
Methods: HIV-infected subjects and healthy controls 1-25 years old were prospectively 
enrolled. Demographics, clinical and laboratory data (including fasting lipids) were 
collected. Food and nutrient intake was assessed via 24-hr dietary recalls performed one-
on-one with a trained investigator every 3 months for one year. Nutrient intake was 
determined from averaged food recall data using NDS-R software and directed by 
research nutritionists. Nutrient intake was compared to Dietary Reference Intakes (DRI) 
and Acceptable Macronutrient Distribution Ranges (AMDR). Analysis utilized non-
parametric and parametric tests and Pearson correlations to evaluate associations. 
 
Results: Subjects with ≥2 food recalls were analyzed (175 HIV+; 43 controls). Groups 
were similar in age, race, sex, body mass index (BMI), and kilocalorie intake (HIV+: 
mean(SD) age=17.4±4.8 years; 95% black; 54% male). Neither group met the DRI for 
vitamins A, D, E, calcium, magnesium, sodium, and potassium (all P<0.01).  HIV+ 
patients did not meet recommendations for pantothenic acid or folate (both P<0.01) and 
had lower %DRI than controls for vitamins A, E, pantothenic acid, magnesium, calcium, 
folate and potassium (P≤0.04). Micronutrient intake that met recommendations for both 
groups still had a lower intake in HIV+ (vitamins K, C, thiamin, riboflavin, copper, 
phosphorus, manganese). Carbohydrate/protein intake were within AMDR for both 
groups; however, %kilocalories from fat was above normal and higher in HIV+ (both 
P=0.02). Both groups consumed less fiber, and more saturated and trans-fat than 
recommended; cholesterol intake was normal. In HIV+, BMI was negatively correlated 
with %DRI for vitamins A, D, E, B6, B12, riboflavin, thiamin, niacin, pantothenic acid, 
folate, magnesium, iron, zinc, copper, potassium and selenium (all P<0.05). Caucasian 
HIV+ patients had significantly greater vitamin D and calcium %DRI than black HIV+ 
patients (p< 0.05). Mean lipid profiles were within a healthy range for both groups. Mean 
serum triglycerides were significantly higher and HDL-C lower in HIV+ subjects (both 
p<0.01). Fiber and trans-fat intake were correlated with triglycerides (r=0.16;P=0.04) and 
low-density lipoprotein (r=0.16;P=0.04), respectively. Total fat intake was correlated 
with triglycerides (r=-0.17;P=0.03). Mean caloric intake was negatively correlated with 
current (r=-0.12;P=0.02) and nadir CD4 counts(r=-0.11;P=0.04). Zinc, riboflavin, and 
magnesium %DRI were correlated with current CD4 (all P<0.01), and vitamin A %DRI 
with nadir CD4 (r=0.10;P=0.05).  In HIV+ subjects not on ART (N=56), HIV-1 RNA 
levels were negatively correlated with protein intake (r=-0.30;P=0.05).   
 
Conclusions: HIV+ youth have inadequate intake of several essential vitamins and 
minerals compared to the DRIs, and lower habitual dietary intake of a variety of 
micronutrients compared to HIV- controls. HIV+ youth consumed higher than 
recommended amounts of dietary fat and lower than recommended amounts of dietary 
fiber. While mean lipid profiles were normal and intake did not correlate with values, the 
HIV+ group had a higher prevalence of dyslipidemia, which long-term, may contribute 
towards a greater risk of cardiovascular disease when combined with poor diet. Intake of 
some nutrients was associated with HIV-related factors, including CD4 counts. Further 
investigation is warranted to determine whether nutrient intake data correlate with plasma 
nutrient concentrations in HIV+ youth and the potential impact of nutritional status on 
immune function, HIV progression, and CVD risk in this patient population.   
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CHAPTER I 
INTRODUCTION 
According to the Centers for Disease Control and Prevention (CDC),1 
approximately 1.2 million people, aged 13 and older, were living with human 
immunodeficiency virus (HIV) infection in the U.S. at the end of 2008.  Almost 43,000 
new diagnoses of HIV infection in the U.S. were made in 2009.  An estimated 8,460 of 
those diagnoses were children and youths between the ages of 0 and 24 years.1 Among all 
age groups, seven and a half percent of the HIV diagnoses in the U.S. in 2009 occurred in 
Georgia.  The only states with a greater percentage of overall HIV diagnoses were 
Florida, New York and Texas.2  New cases of HIV-infection continue to be a problem in 
the U.S. and even more so in Georgia. 
There are a number of nutritional issues affecting HIV-infected individuals.  
Nutritional issues range depending on medications and disease status.  Furthermore, with 
developments in medications, long-term nutritional implications have become a bigger 
concern for those infected with HIV.  In addition to long-term metabolic abnormalities, 
more immediate nutrient deficiencies can also impact the disease status of those living 
with HIV.  Fortunately, vigilant dietary intake by these individuals may limit such issues. 
Prior to the introduction of highly active antiretroviral therapy (HAART), wasting 
syndrome and growth impairment were some of the major nutritional implications in 
children with HIV.3,4   Since the introduction of HAART, children and adults infected 
with HIV are living longer,5,6 and there is less concern about wasting and growth 
impairment.  In contrast, nearly half of the HIV-infected participants in the Reaching for
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Excellence in Adolescent Care and Health (REACH) study,7 a prospective, observational 
cohort study following adolescents’ progression of HIV infection, were either overweight 
or obese.  Furthermore, they found the obesity prevalence among HIV-infected 
adolescents was higher in the southern region of the United States.   
With a decrease in wasting, and increase in survival times and obesity, the 
concern has shifted toward long-term health problems and chronic diseases associated 
with HIV infection and HAART medications.6  Metabolic abnormalities, including 
dyslipidemia, and the risk of cardiovascular disease (CVD) are of growing concern in the 
HIV infected population.8  Studies8,9  have shown the effectiveness of dietary intervention 
on decreasing lipid levels in this population; thus, the first step for improving 
hypercholesterolemia and hypertriglyceridemia in patients with HIV should be 
consultation with a dietitian.10  Barrios et al.11 found that HIV infected individuals that 
complied with a low-fat diet, had significantly lower lipid levels, especially when taking 
protease inhibitors (PI).  For the general population, the American Heart Association 
(AHA) recommends total fat intake to be between 25 and 35% of total calories, saturated 
fat to be less than 7% of total calories, trans fats to be less than 1% of total calories, 
cholesterol to be less than 300mg per day, and to consume 14g of fiber per 1000 calories 
consumed per day, to reduce the risk of CVD.12  CVD is the number one cause of death, 
amongst the general population, in the United States. Due to the increased CVD risk 
factors in HIV-infected patients, these recommendations may need a stricter following by 
the HIV-population.  Fat, saturated fat, trans fats, cholesterol and fiber intake are all 
associated with the risk of developing CVD. 
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Alternatively, malnourishment is still a concern among some HIV-infected 
children and adolescents, especially those taking PI.13  Present treatment guidelines 
include PI as part of the antiretroviral therapy (ART) regimen for children and adults.14  
Children on PI have been shown to have significantly lower body mass index (BMI) and 
z scores for weight for age and height for age.13  Regardless of medication, a higher rate 
of protein oxidation has been seen in HIV-infected children due to the “inability to down-
regulate protein catabolism” in this population.15  Similarly, HIV infected adults have 
been shown to have an increased resting energy expenditure (REE) compared to healthy 
people;16 however, data on REE in children is not as clear.6 Johann-Liang and colleagues 
did not find evidence for an increased REE in children ages 1 to 13 years.3 On the other 
hand, Banerjee and colleagues did find that children on HAART had higher REE than 
those not on HAART, and that weight Z-score was significantly negatively associated 
with REE.5 
Furthermore, studies show that nutritional deficiencies, including selenium, 
vitamin A, calcium, vitamin D, zinc, and glutathione, are not uncommon among children 
with HIV,17-19 even with the introduction of HAART.13   Several studies on adults 
infected with HIV have found micronutrient deficiencies were associated with decreased 
immune status, disease progression to AIDS, and increased mortality.20-27 Assessment of 
nutritional status can be accomplished using Dietary Reference Intakes (DRIs),28-29 which 
are the nutrient reference values derived from years of scientific research that include 
four reference values: Recommended Dietary Allowance (RDA), Adequate Intake (AI), 
Tolerable Upper Intake Level (UL), and Estimated Average Requirements (EAR).  The 
RDA is the “average daily dietary nutrient intake level that is sufficient to meet the 
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nutrient requirements of nearly all (97-98 percent) healthy individuals.”  For some 
nutrients, there is not enough research to establish an RDA, therefore those nutrients have 
an AI, which is considered an adequate amount of intake of the nutrient for healthy 
individuals.  Unfortunately, in those infected with HIV, the RDA may not meet their 
needs, as research30 has suggested that there is a greater utilization of nutrients, possibly 
due to increased oxidative stress.   
Several studies5,31 have shown that nutrition counseling and support improved the 
health of children and adults with HIV, emphasizing the importance of dietary intake 
among the HIV-infected population.  Given the aforementioned nutritional implications 
affecting HIV-infected individuals and that dietary intake is an important environmental 
factor contributing to the health of those infected with HIV,6,32 it is important to 
understand the current dietary intake of this population.  HIV-infected children and 
adolescents are at an even higher nutritional risk due to growth and development 
demands,33 and few studies have thoroughly described the micro- and macro-nutrient 
intake of this population.  Micronutrients play an important role in immune function, and 
studies show that lower micronutrient intakes are associated with mortality and the 
progression of HIV,16 as assessed by biomarkers such as viral load and CD4+ cell 
count.23  CD4 are immune cells that are targeted and inactivated by the HIV-virus, and 
thus decrease in HIV-infected individuals.16  However, research shows micronutrient 
supplements have also had adverse effects on individuals infected with HIV. Therefore, 
The World Health Organization16 (WHO) suggests that an adequate diet is the best 
method for meeting micronutrient needs in HIV-infected individuals. Thus, determining 
deficiencies in micronutrient intake among children and adolescents infected with HIV 
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will provide valuable information for patient care, as will assessing associations between 
intake and HIV-related factors.  Furthermore, given the increased risk factors of CVD in 
the HIV-infected population, the question remains, do HIV-infected children and youth 
follow a heart healthy diet, and does the dietary intake of unhealthy fats and limited fiber 
affect nutritional markers of CVD, such as lipid levels, in this population?  Therefore, the 
objectives of this thesis research are (1) to determine the micro- and macronutrient 
intakes of HIV-infected children and youths, (2) to compare the nutrient intakes to the 
DRI and to the healthy controls, (3) to determine if nutrient intake is associated with 
HIV-related values (CD4+ counts, viral loads), (4) to compare nutrient intake to the 
American Heart Association’s recommendations for a heart healthy diet, and (5) to assess 
the associations between dietary intake of nutrients (fat, saturated fat, trans fat, 
cholesterol and fiber) and serum lipid levels.
  6 
CHAPTER II 
REVIEW OF LITERATURE 
Micronutrient Needs in HIV-Infected Individuals 
Micronutrients are important for maintaining the body’s functions and immune 
system, and deficiencies have been associated with disease advancement and mortality in 
HIV-infected individuals.20-27A U.S. study21 following HIV-infected men over an 8-year 
period, found that increased intake of thiamin, riboflavin, niacin, and vitamin B-6 were 
associated with longer survival.  A 3.5 year study22 following 125 HIV-infected, drug-
using men and women revealed plasma vitamin A, B-12, zinc and selenium deficiencies 
were significantly associated with mortality.  However, after controlling for CD4+ cell 
counts less than 200/mm3, only selenium deficiency was significantly associated with 
increased mortality.  Vitamin B-6 and E did not show any association with mortality.  In 
a study of 400 HIV-infected Kenyan women,23 inadequate serum beta-carotene was 
significantly associated with the immune response and HIV progression biomarkers such 
as viral load, CD4+ cell count and C-reactive protein (CRP).  Increased CRP and viral 
loads were the strongest predictors of inadequate serum beta-carotene.  However, the 
direction of the association was not established.  Fortunately, Baum and colleagues24 
conducted a longer, 18-month study on 90 HIV-infected men to determine nutritional and 
immune status over time and better understand causality.  A significant drop in CD4+ cell 
count occurred after serum vitamin A and B-12 became deficient.  Additionally, they 
found that when serum vitamin A, B-12 and zinc reached sufficient levels, CD4+ cell 
counts were increased and disease progression abated.  On the other hand, in the
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multicenter AIDS Cohort Study that followed 310 men semiannually for over 10 years, 
Tang and colleagues25 found that vitamin A was not associated with progression to AIDS, 
nor was vitamin A or E associated with a decline in CD4+ cell count to less than 
200/mm3.  However, when vitamin E levels were studied in quartiles, “median AIDS free 
time” in the highest quartile of vitamin E intake was 1.5 years greater than in the lower 
quartiles and the adjusted risk of progression to AIDS was 34% lower in the highest 
quartile of intake compared to the lowest quartile.  In an additional study26 following the 
same cohort of men, deficiency in serum B-12 preceded disease progression to AIDS 
after adjusting for CD4+ cell count.  Median time to first AIDS diagnosis was extended 4 
years in those with adequate B-12 concentrations compared to those who were B-12 
deficient, and there was an 87% increased risk of progression to AIDS in the serum B-12 
deficient group.  No association was found between B-6 and folate concentrations and 
progression to AIDS.  Further analysis 27 of dietary intake from the AIDS Cohort Study 
revealed decreased risk of progression to AIDS with the highest intake levels of vitamins 
C, thiamin, and niacin.  Alternatively, increased zinc intake was associated with an 
increased progression to AIDS.  The highest and lowest intakes of vitamin A were 
associated with a higher progression to AIDS. 
Likewise, micronutrient deficiencies are common in individuals infected by HIV.  
Studies20 have shown both insufficient dietary intake and inadequate serum levels of 
some micronutrients in this population.  For instance, Baum and colleagues 24, found 
HIV-infected men were more likely to have serum deficiencies in vitamin B-6, B-12, A, 
E and zinc than the non-infected control group.  In addition, sufficient dietary intake of 
micronutrients above the RDA has been seen in HIV-infected individuals, but with 
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inadequate serum concentrations of those micronutrients, suggesting that HIV-infected 
people have increased needs above the RDA for certain micronutrients.30,34  
In summary, several studies have demonstrated an association between poorer 
health outcomes and micronutrient deficiencies in HIV-infected adults.  Inferior 
outcomes were associated with both serum micronutrient deficiencies and dietary intake 
deficiencies.  Research reveals an association between decreased immune status and 
inadequate vitamin A, B-12, and zinc; increased mortality and inadequate selenium, 
thiamin, niacin, riboflavin and B-6; and progression to AIDS and inadequate vitamins C, 
E, thiamin, niacin and B-12.  Some researchers35 believe that part of the contributory role 
of these vitamins and minerals to the slowing of HIV progression are related to their 
antioxidant effects and ability to reduce oxidative stress.  Oxidative stress is considered 
as an important factor in the pathogenesis of the HIV disease.  Overall, research suggests 
that sufficient micronutrient status may contribute to improved immune status and 
survival. 
Macronutrient Needs in HIV-Infected Individuals 
The World Health Organization16 suggests asymptomatic HIV-infected 
individuals increase calorie intake by 10% and those fighting infection increase calorie 
intake by 20-30% because of increased energy expenditure.  Furthermore, HIV-infected 
children losing weight need to increase their calorie intake by 50-100%. However, 
recommendations on the macronutrient composition for HIV-infected individuals are the 
same as the recommendations for non-infected persons, without a greater need for 
protein.4,16,31,36 The Institute of Medicine (IOM)37 recommends an Acceptable 
Macronutrient Distribution Range (AMDR) of 10 to 35% of energy from protein, 45 to 
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65% of energy from carbohydrates, and 20 to 35% of energy from fat, in adults.  The 
AMDR for children and youths between the ages of 4 and 18 is between 25 and 35% of 
energy from fat and between 10 and 30% of energy from protein.  Carbohydrate 
recommendations are the same for children and youths.  With the advent of ART and the 
increased risk of CVD in these patients, some researchers have suggested a decreased fat 
intake.33  Miller and colleagues38 suggest that HIV-infected children with any “metabolic 
dysfunction” keep fat intake at less than 30% of calories and saturated fat at less than 
10% of calories.  The Academy of Nutrition and Dietetics (AND) also emphasizes a diet 
with less than 7% of calories from saturated fat, less than 1% of calories from trans fatty 
acids, and less than 200 mg of cholesterol each day for HIV-infected individuals with 
hyperlipidemia.36 
 Macronutrient needs vary in individuals infected with HIV and may also vary 
based on disease complications.  Energy needs are increased for the HIV-infected 
individual, and are even greater with infection or if there has been weight loss.  The 
recommendation on the macronutrient breakdown of protein, carbohydrate and fat does 
not differ for the HIV-infected individual; however, research has suggested limiting fat 
intake and the AND has suggested limiting trans fat, saturated fat and cholesterol intake 
in HIV-infected individuals with hyperlipidemia 
Micronutrient Deficiencies and Needs of HIV-Infected Youths 
Increased micronutrient needs may explain malnourishment and nutritional 
deficiencies among HIV-infected children.  Studies19,30 have shown that HIV infection 
may cause micronutrient deficiencies in children.  Steenkamp and colleagues19 showed 
that the nutrients with the greatest prevalence of deficiency in an analysis of serum levels 
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were vitamin A, vitamin D, zinc, and glutathione, which are all important in immune 
regulation.  In this study of children not receiving HAART, they found that children with 
abnormally low levels of zinc and vitamin A had significantly lower CD4+ cell counts 
and higher viral loads.  They did not find any correlations between deficient nutrient 
intake and growth impairment.  Furthermore, Stephensen et al.30 concluded from the 
REACH study, that vitamin C and vitamin E intake in HIV-infected youths must be 
increased due to the greater utilization of these vitamins as a result of increased oxidative 
stress with HIV-infection.  Plasma ascorbate levels were marginally lower in subjects 
with HIV, but intake of vitamin C was sufficient, suggesting “chronic immune 
activation” lowers plasma ascorbate levels.  The positive association found between 
vitamin E intake and plasma alpha-tocopherol in HIV-negative subjects was not seen in 
HIV-positive subjects, suggesting an increased need for vitamin E among youths with 
HIV.  Therefore, these studies19,30 have concluded that nutrition support along with 
nutrient-dense foods and supplements are critical for the treatment of children with HIV.   
Earlier studies4, 18 show conflicting results on micronutrient deficiencies.  
Henderson and colleagues4 saw no differences in serum plasma micronutrients between 
HIV-infected and non-HIV infected individuals, but suggested that there still may be an 
increased need for micronutrients in HIV-infected children.  Furthermore, they found no 
greater micronutrient deficiencies in HIV infected children with growth retardation.  
Fawzi18 suggests that overall, deficiencies of biochemical micronutrients are more 
common among children infected with HIV than those uninfected. 
Similar to adults infected with HIV, HIV-infected children also face micronutrient 
deficiencies that compromise immune and nutritional status.  While research is more 
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limited on children, so far it reveals deficiencies in vitamins A, D, C, E and zinc.  
Deficiencies in vitamins A and zinc have been associated with poorer immune status.  
Furthermore, the chronic disease status of HIV-infected youths may result in increased 
nutrients needs beyond the recommended intakes.   
Current Studies Assessing Nutrient Intake of HIV-Infected Youths 
While several studies have described the intake of HIV infected adults,21,39,40 few 
have thoroughly described the nutritional intake of youths with HIV in the United States.  
Of those that have studied dietary intake in children, very few3 have found a decreased 
energy or macronutrient intake in HIV-infected children and adolescents;4,6,13,32 however, 
deficient micronutrient intakes were uncovered. 
Henderson and colleagues4 assessed dietary intake through 24-hour recalls in 38 
children ages 2 to 11 years old.  The study only described the intake of energy, protein, 
zinc, selenium and vitamin A.  Energy intake of the HIV infected children was 
approximately 100% of the RDA, and protein intake was over 200% of the RDA.  Only 
zinc intake was low at less than 65% of the RDA.  Zinc deficiency is related to changes 
in immune function, which is a concern for this population.  They found no significant 
difference in intakes between HIV-positive and HIV-negative groups. 
In one of the oldest studies41 looking at dietary intake of HIV-infected children, 
Zuin and associates used 3-day food diaries to assess intakes of 33 HIV-infected children 
compared to 16 HIV-negative children.  The analysis only considered energy, protein, 
calcium, phosphorus and iron intake.  All HIV infected children had protein intake 
greater than the RDA.  There were no significant differences in energy and nutrient 
intakes between the HIV-infected children and the controls.  Although, they did find that 
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those patients that were “symptomatic” had slightly decreased energy and nutrient 
intakes, and they were also more at risk for acute complications, which led to an even 
greater reduction of energy and protein intake. 
In one of the REACH studies42, which spanned the U.S., the Block Food 
Frequency Questionnaire (FFQ) was administered to 264 HIV-infected and 127 non-
infected youths between the ages of 12 and 18 years of age.  Energy, vitamin A, C, E, 
iron, and zinc intake were assessed.  No significant differences in nutrient intakes were 
found between HIV-positive and HIV-negative youths.  When compared to the Estimated 
Average Requirements (EAR), 13-38% of the study population had inadequate intakes of 
vitamins A, E and zinc.  Moreover, there were no significant differences in intakes when 
comparing patients by CD4+ cell counts.  Another REACH study7 assessed “diet quality” 
using a modified Healthy Eating Index (HEI), which assessed total fat, saturated fat, 
cholesterol, sodium, and the 5 Food Guide Pyramid food groups.  Poorer-quality diets 
were seen in HIV-positive youths that had higher intakes of fat, saturated fat and 
cholesterol compared to the non-infected controls. 
In an HIV-infected cohort (n=126) aged 3-20 years old, Sharma et al.32 collected 
an average of 5, 24-hour recalls per subject between 1995 and 2004.  They found that the 
dietary intake of the HIV infected children were similar to healthy children, and calorie 
intake was 161% of estimated energy requirements (EER) in males and 140% of EER in 
females.  Fat, protein and carbohydrate intake were all within the AMDR.  Though, 
saturated fat intake was high at 12.6% and 12.7% of kilocalories for males and females, 
respectively.  Protein intake at the beginning of the study was 400% of the RDA, but 
slightly decreased as nutrition education was provided every 3 months. 
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In a group of HIV-infected 4-17 year olds from Brazil, Tremeschin and 
colleagues13 used an adapted semi-quantitative FFQ to assess dietary intake.  They found 
no difference in macronutrient and energy intakes between the HIV-positive and HIV-
negative groups, but they did see excessive dietary fat intake (38.5% of kilocalories) 
amongst both groups.  The authors concluded that the diet of this population must be 
monitored due to the high lipid consumption and the risk of CVD in this group. 
Few studies have thoroughly assessed micro- and macro-nutrient intakes of 
youths with HIV.  Deficient intakes were found for vitamins A, E and zinc, but none 
were seen for the macronutrients.  In contrast, excess intake of protein, fat, saturated fat 
and cholesterol among HIV-infected youths was common. 
HIV, Dyslipidemia, and Cardiovascular Disease Risk 
Several studies38,43 emphasize a growing concern for an increased risk of CVD 
due to lipid abnormalities, lipodystrophy, and vascular structural changes in children 
infected with HIV.  Lipid abnormalities, or dyslipidemia, among HIV-infected 
individuals include one or more of the following: increased fasting total cholesterol (TC) 
greater than 200mg/dl, serum triglycerides (TG) greater than 140mg/dl, or low-density 
lipoprotein (LDL-C) greater than 130mg/dl, or decreased high-density lipoprotein (HDL-
C) less than 40mg/dl.13,38,43,44  These characteristics of high blood cholesterol are more 
specifically called hyperlipidemia because the levels are elevated.  Lipodystrophy is 
loosely defined as fat redistribution in which there is an accumulation of visceral fat 
around the stomach and back of the neck, and a wasting of fat in the extremities and 
face.38 Changes in the vascular structure, or damage to the arterial walls, have been 
characterized by thickening of the right and left common carotid arteries and a decreased 
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brachial artery flow mediated dilation, a measure of arterial function, in those infected 
with HIV.43  Chronic infection and inflammation in HIV-infected individuals seems to 
increase atherosclerotic processes, which creates critical risk factors for CVD.   
In a study10 looking at the effect of ART drugs on lipid changes, it was found that 
10% of children on ART might require hyperlipidemia intervention due to the increased 
risk of inflammation from HIV infection.  In a cohort of 94 children ages 1 through 18 
that had taken PI for at least 2 years, 62% had dyslipidemia.44  Miller and colleagues38 
believe that an alteration in diet can positively affect HIV patients with “metabolic 
dysfunction.”  They suggested that well-balanced diets, high in fiber, micronutrients and 
antioxidants might offset nutrient deficiencies.  Furthermore, they advise these patients to 
keep dietary fat at <30% of kilocalories and saturated fat at <10% of kilocalories.   
In Brazil, Tremeschin and colleagues,13 studied 4 groups of 4-17 year olds that 
were either HIV-positive on nucleoside or non-nucleoside reverse transcriptase inhibitors 
(NRTI, NNRTI), PI for more than 2 months, PI for less than 2 months, or were healthy 
HIV-negative children.  They found no statistical differences in hyperlipidemia between 
any of the groups, suggesting that the HAART regimen alone does not increase 
dyslipidemia.  On the other hand, they found that triglycerides were higher in those 
taking PI.  Both groups had excessive dietary lipid intake, which along with the increased 
concern for CVD risk in children with HIV, suggests that the diet in this population needs 
to be monitored.   
Common carotid intima-media thickness (IMT), or the arterial wall thickness of 
those arteries that supply the head and neck with blood, is a marker for atherosclerosis in 
children at risk for CVD.45  A few studies examined IMT, along with other risk factors 
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for CVD, in HIV-infected youths to determine their risk for CVD.  Several risk factors 
for CVD were studied in 83 HIV-infected children in London.43  Triglyceride, non-HDL 
cholesterol, and apoB levels were all significantly higher in HIV-infected children when 
compared to the control group.  HDL cholesterol levels were significantly lower in the 
HIV group.  Furthermore, they found that children treated with ART had higher total 
cholesterol than children not treated with ART.  This study also looked at vasculature in 
the groups and determined that the average of the right and left common carotid artery’s 
IMT was significantly higher in the HIV infected children compared to the non-infected.  
Those children on PI had significantly higher IMT than those not treated with PI.  
Moreover, flow mediated dilation (FMD) of the brachial artery was lower in HIV 
infected children compared to controls; meaning that the HIV infected children had 
increased arterial stiffness.  PI patients had significantly lower FMD than non-PI patients.  
The authors concluded that vascular changes are occurring at young ages in the HIV 
infected population, supporting the concern for the increased risk of atherosclerosis and 
CVD among these patients.  A study by Vigano and colleagues45 in young adults and 
adolescents with HIV supported these results.  They found that the common carotid IMT 
was higher, after controlling for confounders, in the HIV-infected group than in the 
controls that were matched for age, gender and BMI.  IMT was higher among those 
patients on ART. 
 Shah et al.40 looked at the role of diet in dyslipidemia in 51 HIV-infected adults 
using 3-day food records to assess macronutrient intake.  Despite, the population being 
adults, this study is worth noting due to the correlations made between diet and lipid 
levels.  They found increased protein and animal protein were positively correlated with 
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increased total cholesterol, triglycerides, and non-HDL cholesterol.  Trans fats were 
positively correlated with triglyceride levels.  Moreover, soluble fiber intake, which was 
low, was negatively correlated with total cholesterol, triglycerides, and non-HDL 
cholesterol.  They did not find any associations between lipid levels and omega-3 fatty 
acids, cholesterol, and saturated fat intake.  Of the 51 subjects, all with exposure to PI 
therapy, 50% had either high or very high triglycerides, 50% had either borderline-high 
total cholesterol or high total cholesterol, and 86% of men and 68% of women had LDL 
> 130 mg/dL. 
 Studies have also assessed the acute myocardial infarction (AMI) rates among 
HIV-infected adults to determine outcomes of CVD risk factors.  Triant and colleagues46 
looked at 3,851 HIV-infected patients and 1,044,589 non-HIV patients at Boston 
hospitals between 1996 and 2004.  The amount of AMI events was two times greater in 
the HIV-infected patients compared to the controls.  This study also found that the HIV-
patients had significantly higher rates of hypertension, diabetes and dyslipidemia.  
Unfortunately, there are insufficient studies to determine the adverse outcomes of the 
markers of CVD risk in children.38 
 Several studies have revealed that HIV-infected individuals have many increased 
risk factors for atherosclerosis and CVD.  Dyslipidemia, increased arterial stiffness, 
thickening of the arteries, and increased AMI events have commonly been seen in HIV 
research.  Research has also suggested that a well-balanced diet with proper micro- and 
macro-nutrient intake may help improve these risk factors in the HIV-population. 
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Literature Review Summary 
Research has revealed a number of nutritional issues affecting HIV-infected 
individuals.  Micronutrients play an important role in immune function, and studies show 
that lower micronutrient intakes and serum levels are associated with disease 
advancement and mortality in HIV-infected individuals.  While energy needs are 
increased for the HIV-infected individual, there is not a need for a different macronutrient 
composition of protein, carbohydrate or fat. However, research has suggested limiting fat 
intake, trans fat, saturated fat and cholesterol intake in HIV-infected individuals with 
hyperlipidemia. Hyperlipidemia is common among HIV-infected individuals and several 
studies have revealed many increased risk factors for atherosclerosis and CVD.  
Dyslipidemia, increased arterial stiffness, thickening of the arteries, and increased AMI 
events were more commonly seen in HIV-infected individuals than in those not infected.   
Children with HIV also face micronutrient deficiencies that compromise immune and 
nutritional status, and research suggests that the chronic disease status of HIV-infected 
youth may result in increased nutrients needs beyond the recommended intakes.  
Unfortunately, few studies have thoroughly assessed micro- and macro-nutrient intakes 
of youth with HIV.  The few studies that have assessed intakes, found energy and 
macronutrient deficiencies were uncommon.  In contrast, excess intake of protein, fat, 
saturated fat and cholesterol was common among HIV-infected youths.  
Research suggests that sufficient micronutrient status may contribute to improved 
immune status and survival and that a well-balanced diet with the proper macronutrient 
intake may help improve CVD risk factors in the HIV-population.  Additionally, The 
World Health Organization16 suggests that an adequate diet is the best method for 
  
18
meeting micronutrient needs in HIV-infected individuals as opposed to taking 
supplements.  Therefore, determining deficiencies in micronutrient intake among children 
and adolescents infected with HIV will provide valuable information regarding the 
nutrition counseling that may be needed to provide these youths with healthier and longer 
lives.  Furthermore, given the research showing HIV-infected individual’s increased risk 
factors of CVD, it is important to know whether HIV-infected children and youths follow 
a heart healthy diet, and if the intake of nutrients such as fats and fiber influence 
nutritional markers of CVD, such as lipid levels.  Only one study was found which 
looked at associations between dietary intakes and lipid profiles.
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CHAPTER III 
METHODS AND PROCEDURES 
Participants 
HIV-Infected 
200 documented HIV-infected children, adolescents and young adults (ages 1-25) 
enrolled in the Infectious Disease Program (IDP) at the Ponce de Leon HIV Clinic of the 
Grady Health System in Atlanta, Georgia were recruited for the original study titled, 
“Vitamin D and cardiovascular biomarkers in HIV-infected children and young adults”.   
Inclusion criteria  
All individuals, 1-25 years of age, with documented HIV-1 infection (positive 
HIV-1 antibody test, confirmed by western blot), who obtain their medical care at the 
IDP (Ponce Center) were eligible for the study.  
Exclusion criteria  
Patients who had scheduled “sick visit” appointments, or were found to be acutely 
ill during their regular visits, were not eligible at that visit, and were re-evaluated at their 
next routine or follow-up visit for enrollment in the study. “Acutely ill” was defined as 
having an oral or axillary temperature >100.4°F, significant upper or lower respiratory 
tract symptoms, acute otitis media, pharyngitis, or other notable signs or symptoms 
consistent with acute illness or opportunistic infection that would likely interfere with 
inflammatory marker measurements. Once resolution of signs and symptoms had been 
shown for at least one month, the patient was again eligible for the study. Stable or well-
controlled chronic infectious or inflammatory conditions were not exclusionary, but were
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noted in the data collection forms for accurate data analysis. Children under 1 year of age 
were ineligible due to an immature immune system and inability to interpret 
inflammatory marker levels at this age. 
Recruitment of HIV-infected subjects 
 Subjects were recruited in several ways, including (1) recruitment mailing; (2) 
phone call prior to scheduled appointment; (3) approached by study staff during routine 
medical appointment; and (4) case manager/physician referrals. A flyer was mailed to all 
potentially eligible patients at the IDP at one time with a general description of the study 
and a copy of the informed consent.  These patients had regular appointments scheduled 
at the IDP within the upcoming 3 months (as soon as within 1 week or as long as 3 
months from the time of the flyer mailing). Study staff also called patients a few days 
before their scheduled appointments to tell them about the study and ask them to arrive at 
their appointments after at least 8 hours of fasting if interested in learning more about the 
study for potential participation. Patients/families were approached during their routine 
visits by study staff, and if interested and eligible, were consented and enrolled into the 
study. Case managers and patient physicians were also made aware of the study by a 
general flyer, and told patients about the study. If patients were interested, they were 
referred to the study staff. In all cases, subjects were given ample time to review the 
consent forms and ask questions.  
Controls 
 A small median age-matched control group (n=50) with similar proportions of 
sex and race was recruited and enrolled for comparison to the HIV-infected group. The 
control group had similar study procedures to that of the HIV-infected group except that 
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HIV-related laboratory and clinical information were not collected.  Controls were 
recruited from the clinic, as either uninfected patients who received their regular health 
care at the clinic, or were uninfected siblings or relatives of the HIV-infected patients, or 
from physician referrals. 
Inclusion criteria  
Healthy uninfected children and young adults, 1-25 years of age, were included. 
Exclusion criteria 
 Individuals with current or recent infectious or inflammatory illness, known 
chronic disease, hypertension, or receiving any prescription medication known to affect 
inflammatory or endothelial activation markers were excluded.  Individuals were 
excluded if they were at high-risk of having or acquiring HIV by either (1) engaging in 
sexual activity with a known HIV partner currently or previously without no intercurrent 
negative HIV test, (2) sharing needles for drug injection currently or previously without 
no intercurrent negative HIV test; (3) have had another sexually transmitted disease 
without acquiring HIV testing; or (4) the investigator or subject feels that he/she may be 
infected and has not had a negative HIV test.  Subjects 13 years of age or older were 
screened for HIV before enrollment with the OraQuick Advance Rapid HIV test. 
Recruitment of controls 
 Healthy volunteers were recruited in several ways, including (1) case 
manager/physician referrals of uninfected patients who receive their routine medical care 
at the IDP or of relatives of the HIV-infected patients seen at the IDP; (2) uninfected 
patients seen at the IDP for their routine medical care and/or their guardians were 
approached by study staff during their medical appointments; (3) HIV infected patients 
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and/or guardians were told during their regular appointments and in the recruitment 
mailing that we are looking for uninfected healthy volunteers so they can refer their 
healthy friends or relatives. Volunteers were given copies of the informed consent forms 
and verbal information about the study. Interested volunteers returned to the clinic for a 
scheduled research visit. In all cases, volunteers were given ample time to review the 
consent forms and ask questions. 
All Participants 
Consent and confidentiality 
Study staff fully explained all assessments to the patient and/or legal caregiver, 
and asked for their written consent to participate.  All parents or legal guardians and 
subjects ≥18 years of age provided written informed consent to participate in the study, 
and those subjects 17 years of age signed the written consent along with their parent or 
legal guardian.  Subjects ages 6-10 years gave verbal assent and those 11-16 years gave 
written assent.  Details about the study, including its benefits and potential risks were 
explained to the patients or their parent/guardian. 
All information regarding the patient remained confidential to the extent allowed 
by law.  Unique numeric subject numbers were used for data entry. 
Compensation  
Subjects received $50 after completion of all study procedures to compensate for 
time and transportation costs (with the exception of the follow-up 24-hour food 
consumption recalls). If a subject had to return to the clinic for a separate fasting blood 
draw, the subject received $50 at the time of their return. 
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Data Collection 
Data collection began May of 2010 and was completed in January of 2012.  
Clinical measurements collected include weight, height, standardized waist and hip 
measurements (based on procedure recommendations from the Metabolic Study Group of 
the AIDS Clinical Trials Group), alcohol intake, smoking habits, physical activity level, 
family history of CVD, CD4 counts, HIV-1 RNA (viral load) and fasting lipoprotein 
profile (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides).  
Information was also collected on medication use, demographics, and medical conditions.  
Extensive medical chart evaluations were conducted to collect detailed information on 
past and current medical diagnoses, ART use and history (including calculation of 
cumulative exposure to each class of antiretrovirals), CD4 cell count nadir, current ART 
and non-ART medication use, HIV stage based on CDC classification system, calculation 
of HIV duration in months, and methods of HIV acquisition (vertical or behavioral).  
Relevant medical information on the control group was collected through interview. 
Laboratory Assessments 
 Subjects fasted for ≥8 hours prior to blood sampling.  Plasma was extracted and 
stored at -80° C until analysis without prior thawing.   
Future measurements 
 Extra plasma was obtained and stored for measurements of additional 
micronutrient levels and inflammatory/endothelial activation markers for future, related 
studies. Stored samples were labeled with subject number only. Subject study numbers 
matched to name were stored in a separate location on a password-protected computer. 
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Dietary intake 
Each subject or guardian completed an age-appropriate, semi-quantitative, Block 
Food Frequency Questionnaire (FFQ), and a total of four, 24-hour food consumption 
recalls.  One, 24-hour recall was obtained for each season of the year, for each subject, to 
total four recalls per subject.  Food intake over the last 24 hours was reported by the 
subject and amounts were entered into Nutrition Data System for Research (NDS-R), 
available through the Clinical Interaction Network (CIN) of the Atlanta Clinical & 
Translational Science Institute (ACTSI), which is a dietary analysis program designed for 
the collection and analysis of 24-hour dietary recalls. NDS-R provided a detailed analysis 
of macro- and micro-nutrient intake in units per day. The 24-hour food consumption 
recalls were either obtained by telephone or on subsequent routine visits to the clinic, by 
trained investigators. 
Research Design 
The design of the current study was cross-sectional and exploratory, intending to 
fully describe the nutrient intake of HIV-infected youth.  The study protocol was 
approved by Emory University’s Institutional Review Board (IRB FWA# 00005792; 
registration #s 569 & 570).  This study analyzed the aforementioned data that was 
previously collected for the original study that examined vitamin D’s role in 
cardiovascular health among 200 HIV-infected patients and 50 controls, ages 1-25.  The 
original study specifically looked at inflammatory cytokines and endothelial activation 
markers, and the Block FFQ was used to assess vitamin D status.   
The current study assessed nutrient intakes, using the 24-hour recalls that were 
collected and analyzed in NDS-R, and compared intakes to the DRIs, AMDRs, and the 
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recommendations by the American Heart Association for the prevention of CVD.   The 
study used the same sample population as the original study including all subjects that 
completed at least two, 24-hour recalls.  Subjects with less than two, 24-hour recalls 
collected were excluded. Also excluded were 24-hour recalls that were obvious outliers 
and the subjects were suspected of over- or under-reporting dietary intake for that 
specific recall (less than 500 kilocalories or greater than 5000 kilocalories in one 24-hour 
period).  The recalls included in analysis were collected every 3 months for one year to 
capture seasonal changes in dietary intake, as well as day-to-day variation in diet.  The 
micro- and macronutrient intakes of the 24-hour recalls were compared to the DRIs and 
AMDR given the age of the child or adolescent on the day of intake.  DRI varies 
depending on age and gender.  Percent of DRI was then determined based on the youth’s 
IOM life stage group (age and gender) on the date of intake.  The percent of DRI for each 
intake date was then averaged for each individual subject.  The average micro- and 
macronutrient intake and percent DRI was the basis for all dietary analysis of this study.  
The IOM recommends using at least two, 24-hour recalls on nonconsecutive days to 
assess usual intake.47   
Intake of all micro- and macronutrients were assessed to see if the participants 
were meeting the RDA, AI, or AMDR for each individual nutrient.  The IOM47 
recommends comparing micronutrient intake to the Estimated Average Requirement 
(EAR) for the general population. However, the World Health Organization recommends 
that children and adults with HIV meet at least the Recommended Dietary Allowance 
(RDA);16 therefore, intake of micronutrients were compared to the RDA.  For those 
nutrients without an RDA, intake was compared to the Adequate Intake (AI).  The mean 
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composition of macronutrient intake was compared to the AMDR.   
The study population was separated into two groups: HIV-infected youth (HIV+) 
and HIV-negative controls (HIV-) with similar demographics.  Calorie, BMI, waist-to-
hip ratios, lipid profiles, and macro- and micronutrient intake were compared between the 
groups.  Nutrient intake was also compared between race and gender.  Furthermore, fat, 
fiber, trans fatty acids, saturated fatty acids, and cholesterol intake was compared to the 
recommendations of the American Heart Association.  Fasting lipid levels, including total 
cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides, were individually 
compared between groups and against standards of 200mg/dL, 130mg/dL, 40mg/dL, and 
140mg/dL, respectively.  Associations between nutrient intake and BMI, CD4+ counts, 
viral loads, and lipid profiles were analyzed. 
Statistical analysis 
Sample Size and Power Considerations: Table 1 provides power calculations for 
correlation.48 Approximately 153 HIV-infected children provides 80% statistical power to 
a correlation coefficient of 0.20.  
Table 1.  Sample Size and Power to Determine the Effect of Diet (i.e., Saturated Fat, 
Trans Fat, Cholesterol, and Fiber) on Lipid Levels (α1 = 0.05) 
Outcome Power Sample 
Size 
Correlation 
Coefficient, r 
Hyperlipidemia    
 .80 617 0.10 
 .80 153 0.20 
 .80 68 0.30 
 .80 37 0.40 
 .80 22 0.50 
 
Descriptive statistics, such as mean ± SD, were used to describe micronutrient and 
macronutrient intake, as well as age, BMI, and lipid levels for both the HIV+ and HIV- 
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groups.  Frequencies tables were used to describe gender, race, ART use, and deficient 
nutrient intakes.  All variables were checked for normality.  If variables were not 
normally distributed, log transformations were performed and normality was again 
assessed.  If the variables were not normally distributed after log transformations, non-
parametric tests were used for analysis.  The subject’s average intake was compared to 
the DRI using one-sample t-tests, comparing the % DRI of the deficient micronutrient 
intakes to a test value of 1.0 or 100% DRI.  For between-group comparisons of nutrients, 
BMI, age, waist measurements, and lipids, normally distributed variables were compared 
using independent t-tests, and non-normally distributed variables were compared using 
Mann-Whitney U tests.  Lipid levels (total cholesterol, LDL, HDL, and triglycerides) 
were compared to healthy standards using one-sample t-tests.    One-way ANOVA and 
Bonferroni post-hoc comparisons were used to determine differences between race in 
nutrient intakes. Pearson’s correlation coefficient (parametric) or Kendall’s Tau (non-
parametric) looked at the associations between nutrient intake and age, BMI, lipid levels 
and HIV-related factors. Additional regression analysis was not performed on 
correlations, as only weak associations were found.  A P value < 0.05 was considered 
significant. SPSS 18.0 was used to analyze the data. 
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CHAPTER IV 
RESULTS 
A total of 674 24-hour recalls were analyzed.  558 recalls were analyzed for the 
HIV+ group and 113 recalls were analyzed for the control group. The HIV+ group had 75 
subjects with 4 recalls (43% of subjects), 58 subjects with 3 recalls (33% of subjects), 
and 42 subjects with 2 recalls (24% of subjects).  On average, there were 3.2 recalls per 
subject in the HIV+ group.  The control group had 7 subjects with 4 recalls (16% of 
subjects), 13 subjects with 3 recalls (30% of subjects), 23 subjects with 2 recalls (53% of 
subjects).  On average there were 2.6 recalls per subject in the control group. 
Study Population 
Upon excluding all subjects with less than two 24-hour recalls, 175 HIV-infected 
subjects and 43 healthy controls were included in the analysis.  Subject characteristics are 
summarized in Table 1.  Antiretroviral (ART) medication use is summarized in Figures 1 
and 2, and perinatal infection frequencies are given in Figure 3.  
Age was not normally distributed and could not be log transformed.  Mann-
Whitney U test showed that there was no significant difference between groups for age 
(P=0.688).    The range of age for HIV-infected was 1.46 to 24.41 years.  The age range 
for the controls was 5.5 years to 26.39 years. 
Chi-squared tests were used to determine if there was a significant difference 
between groups for race and gender, as these are categorical variables.  There was no 
significant difference in race (P=0.183) or gender (P=0.804) between the HIV+ group 
and the control group.
  
BMI was not normally distributed. Upon log transformation, BMI was normally 
distributed and an independent t
mean BMI between groups (P=0.716).
Waist-to-hip ratios were normally distributed and independent t
difference between the groups (P=0.124).
Table 1. Subject Characteristics
Mean ± SD  or no. (%) 
 
Age (Years) 
Race Black 
White 
Latino 
Gender Male 
Female 
Body Mass Index (kg/m2)
Waist-to-Hip Ratio 
 
Figure 1.  
-test showed that there was no significant difference
 
-tests revealed no 
 
 
HIV+ (n=175) Controls (n=43)
17.44 ± 4.79 17.26 ± 6.14 
166 (94.9%) 39 (90.7%) 
6 (3.4%) 4 (9.3%) 
3 (1.7%) 0 (0%) 
94 (53.7%) 24 (55.8%) 
81 (46.3%) 19 (44.2%) 
 22.53 ± 5.72 22.16 ±5.17 
0.85 ± 0.08 0.83 ±0.07 
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 P-value 
0.688 
0.183 
0.183 
0.183 
0.804 
0.804 
0.813 
0.124 
  
Figure 2. 
Figure 3. 
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Dietary Intake of HIV-infected Subjects and Controls 
Energy intake is summarized in Table 2.  Total calorie (energy) intake from the 
four 24-hour recalls, over the course of the study, was averaged for each subject.  Energy 
intake was normally distributed; therefore, an independent t-test was used to calculate 
any difference in means between the HIV+ and HIV- group.  There was no significant 
difference between groups in mean energy intake. 
Table 2. Energy Intake 
Mean ± SD HIV+ HIV- P-value 
Energy (kcal) 1953.9 ± 610.87 1990 ± 540.8 0.723 
Median Energy 1859 kcal 1997 kcal  
 
Micronutrient intake 
A summary of the mean percent of DRI intake for the nutrients analyzed is 
presented in Table 3.  For the nutrients analyzed, the DRIs recommended by the IOM are 
given in Table 4 for a reference.  For the HIV-infected group, mean micronutrient intake 
was less than 100% of the DRI for vitamin A (77.61% ± 120), vitamin D (27% ± 21.25), 
vitamin E (54.05% ± 33.67), pantothenic acid (87.47%± 38.24), folate (96.81%± 48.27), 
calcium (57.57% ± 27.22), magnesium (63.72% ± 30.4), and potassium (39.49% ± 
14.09).  Mean intake of sodium (236.27% ± 83.08) was greater than the recommended 
DRI.  For the HIV+ subjects, all variables were significantly different than the 100% DRI 
with P-values <0.001. 
For the controls, micronutrient intake was less than 100% of the DRI for vitamin 
A (96.83%± 74.98), vitamin D (35.96% ± 31.75), vitamin E (64.57% ±27.92), calcium 
(69.45% ± 30.68), magnesium (80.21%± 40.35), and potassium (44.95% ± 12.70), and 
greater than the recommended DRI for sodium (247.15% ± 74.3).  All micronutrients 
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consumed suboptimally were significantly different than the 100% DRI with P-
values<0.001.  Median nutrient intake can be found in Table 4. 
Macronutrient Intake 
Mean percent calories from carbohydrate, fat, and protein fell within the 
acceptable macronutrient distribution range (AMDR) for the control group.  Mean 
percent calories from carbohydrate and protein fell within the AMDR for the HIV+ 
group. Mean fat intake significantly exceeded the AMDR for HIV-infected subjects 
(36.02% ± 5.67, P=0.018) only. See Figure 4.  
Table 3. Mean % DRI (RDA or AI) ± SD 
 HIV-Infected (N=175) Controls (N=43) 
 Mean Intake that 
Met DRI 
Mean 
Intake That 
Did Not 
Meet DRI 
Mean Intake 
That Met DRI 
Mean Intake 
That Did Not 
Meet DRI 
MICRONUTRIENTS  
Vitamin A  77.61%± 
120 
 96.83%± 74.98 
Vitamin D  27%± 21.25  35.96%± 31.75 
Vitamin E  54.05%± 
33.67 
 64.57%±27.92 
Vitamin K * 115.04%± 120.9  152.68%± 
146.03 
 
Vitamin C 127.8%± 109.39  170.35%± 
110.79 
 
Thiamin 145.3%± 53.57  170.75%± 79.8  
Riboflavin 154.47%± 69.34  196.42%± 
101.36 
 
Niacin 259.71%± 84.18  285.43%± 90.29  
Pantothenic Acid *  87.47%± 
38.24 
106.06%± 54.79  
B-6 142.99%± 58.77  162.19%± 64.81  
Folate  96.81%± 
48.27 
114.10%± 54.36  
B-12 208.35%±327.76  225.29%±177.97  
Calcium  57.57%± 
27.22 
 69.45%± 30.68 
Phosphorus 117.12%± 53.53  137.1%± 58.62  
Magnesium  63.72%±  80.21%± 40.35 
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30.4 
Manganese * 114.84%± 53.57  132.97%± 48.87  
Iron 126.63%± 69.72  131.21%± 66.78  
Zinc 108.33%± 46.89  111.72%± 41.63  
Copper 133.67%± 174  151.89%± 95.56  
Selenium 206.61%± 77.5  228.41%± 85.83  
Sodium *  236.27%± 
83.08 
 247.15%± 74.3 
Potassium *  39.49%± 
14.09 
 44.95%± 12.70 
 
MACRONUTRIENTS 
 Intake 
Within AMDR 
Intake 
Exceeds 
AMDR 
Intake 
Within AMDR 
Intake 
Exceeds 
AMDR 
Mean % kcal from 
FAT 
 36.02%± 
5.67 
33.8%± 5.07  
Mean % kcal from 
CHO 
48.16%± 7.02  51.03%± 5.57  
Mean % kcal from 
PRO 
15.65%± 3.55  14.87%± 2.6  
 
 
 
 
 
AMERICAN HEART ASSOCIATIONS RECOMMENDATIONS 
 Met  Did not 
meet  
Met  Did not meet  
Mean % kcal from 
saturated fat (% of 
7% 
recommendation) 
 11.55% ± 
2.3 
(165.01%± 
32.8 ) 
 11.12%± 
2.18(158.8%± 
31.1) 
Mean % kcal from 
TRANS- fat (% of 
1% 
recommendation) 
 1.45%± 
0.55 
(145.10%) 
 1.15%± 0.57 
(115%) 
Cholesterol (% of 
300mg) 
84.97%± 45.03  87.67%± 43.56  
Fiber (% of 
recommended 
intake 
(14g/1000kcal)) 
 43.3% ± 
13.7 
 48.81%± 15.67 
* Denotes micronutrient with adequate intake (AI) instead of an RDA 
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Table 4. DRIs of Nutrients Analyzed: Recommended Dietary Allowances, Adequate 
Intakes, and Acceptable Macronutrient Distribution Ranges37 
 Children Males Females 
Nutrients 1-3y 4-8y 9-13y 14-18y 19-30y 9-13y 14-18y 19-30y 
MICRONUTRIENTS 
Vitamin A 
(µg/d) 
300 400 600 900 900 600 700 700 
Vitamin D 
(µg/d) 
15 15 15 15 15 15 15 15 
Vitamin E 
(mg/d) 
6 7 11 15 15 11 15 15 
Vitamin K* 
(µg/d) 
30 55 60 75 120 60 75 90 
Vitamin C 
(mg/d) 
15 25 45 75 90 45 65 75 
Thiamin 
(mg/d) 
0.5 0.6 0.9 1.2 1.2 0.9 1.0 1.1 
Riboflavin 
(mg/d) 
0.5 0.6 0.9 1.3 1.3 0.9 1.0 1.1 
Niacin 
(mg/d) 
6 8 12 16 16 12 14 14 
Pantothenic 
Acid * 
(mg/d) 
2 3 4 5 5 4 5 5 
B-6 (mg/d) 0.5 0.6 1.0 1.3 1.3 1.0 1.2 1.3 
Folate (µg/d) 150 200 300 400 400 300 400 400 
B-12 (µg/d) 0.9 1.2 1.8 2.4 2.4 1.8 2.4 2.4 
Calcium 
(mg/d) 
700 1000 1300 1300 1000 1300 1300 1000 
Phosphorus 
(mg/d) 
460 500 1250 1250 700 1250 1250 700 
Magnesium 
(mg/d) 
80 130 240 410 400 240 360 310 
Manganese * 
(mg/d) 
1.2 1.5 1.9 2.2 2.3 1.6 1.6 1.8 
Iron (mg/d) 7 10 8 11 8 8 15 18 
Zinc (mg/d) 3 5 8 11 11 8 9 8 
Copper (µg/d) 340 440 700 890 900 700 890 900 
Selenium 
(µg/d) 
20 30 40 55 55 40 55 55 
Sodium * 
(g/d) 
1.0 1.2 1.5 1.5 1.5 1.5 1.5 1.5 
Potassium * 
(g/d) 
3.0 3.8 4.5 4.7 4.7 4.5 4.7 4.7 
MACRONUTRIENTS: Acceptable Macronutrient Range (% of kilocalories) 
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Fat 30-40 25-35 20-35 25-35 20-35 
Carbohydrate 45-65 
Protein 5-20 10-30 10-35 10-30 10-35 
* Denotes micronutrient with adequate intake (AI) instead of an RDA 
 
 
Table 5. Dietary Median Intake for the HIV+ and Control Groups  
 
HIV+ Controls 
 
Percentiles Percentiles 
25 Median 75 25 Median 75 
MICRONUTRIENTS (% DRI) 
PercentDRI_A 37.41% 58.61% 81.43% 54.07% 77.22% 110.99% 
PercentDRI_D 12.41% 21.44% 36.36% 16.69% 27.46% 46.98% 
PercentDRI_E 33.40% 45.00% 65.19% 43.21% 63.15% 78.32% 
PercentDRI_K 48.59% 74.61% 129.76% 62.09% 96.47% 148.06% 
PercentDRI_C 53.58% 97.50% 182.03% 93.01% 136.27% 211.44% 
PercentDRI_Thiamin 107.69% 
139.33% 179.13% 118.77% 151.64% 198.23% 
PercentDRI_Riboflavin 112.21% 
138.08% 179.73% 122.88% 154.99% 230.33% 
PercentDRI_Niacin 200.73% 
252.31% 314.30% 232.28% 272.68% 339.92% 
PercentDRI_Pantothenic 
Acid 
62.20% 79.59% 103.09% 72.55% 95.16% 111.00% 
PercentDRI_B6 105.08% 
130.00% 173.48% 116.81% 154.29% 190.04% 
PercentDRI_Folate 66.88% 88.33% 114.61% 71.98% 103.34% 138.04% 
PercentDRI_B12 97.93% 155.46% 213.56% 129.72% 174.83% 296.38% 
PercentDRI_Calcium 40.15% 53.44% 67.88% 52.79% 57.58% 73.84% 
PercentDRI_Phosphorus 80.86% 107.88% 143.16% 89.51% 119.82% 167.97% 
PercentDRI_Magnesium 43.05% 55.81% 73.34% 48.00% 68.81% 102.31% 
PercentDRI_Manganese 80.07% 104.96% 130.88% 89.45% 124.25% 166.39% 
PercentDRI_Iron 72.87% 115.70% 162.75% 68.96% 124.14% 164.18% 
PercentDRI_Zinc 75.93% 100.49% 129.35% 77.93% 102.80% 137.48% 
PercentDRI_Copper 82.56% 107.89% 140.83% 98.16% 133.67% 177.16% 
PercentDRI_Selenium 149.26% 
199.33% 251.20% 163.85% 222.59% 276.05% 
PercentAI_Sodium 178.12% 
219.26% 285.18% 196.06% 239.12% 282.98% 
PercentDRI_Potassium 29.62% 37.11% 47.14% 35.66% 45.66% 54.03% 
MACRONUTRIENTS (% of kcals) 
Percent_KCal_from_CHO 43.51 48.09 53.56 47.72 51.98 53.85 
Percent_KCals_from_PRO 13.48 15.02 17.89 13.09 14.66 16.20 
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Percent_KCals_from_SFA 9.99 11.34 12.84 10.13 10.91 12.20 
Percent_KCals_from_Fat 32.24 35.93 39.79 31.57 33.87 36.60 
Percent_KCalsfrom TransFat 1.03% 1.35% 1.77% 0.81% 0.97% 1.36% 
OTHER (% of 
recommendation) 
      
PercentDRI_Cholesterol 52.78% 74.70% 111.91% 62.57% 79.36% 107.26% 
Percent_Recommended_Fiber 34.33% 41.06% 49.24% 35.97% 46.39% 58.76% 
 
 
Table 6. Frequencies of Subjects with Suboptimal Nutrient Intake 
 Controls (n=43) HIV+ (n=175) 
Fiber 43 (100%) 174 (99.4%) 
Vitamin A 29 (67.4%) 144 (82.3%) 
Vitamin D 41 (95.3%) 173 (98.9%) 
Vitamin E 40 (93.0%) 163 (93.1%) 
Calcium 37 (86%) 162 (92.6%) 
Magnesium 32 (74.4%) 152 (86.9%) 
Potassium 43 (100%) 175 (100%) 
Pantothenic Acid 27 (62.7%) 127 (72.6%) 
Folate 20 (46.5%) 107 (61.1%) 
Prevalence of excess nutrient intake above the recommended intake 
Sodium 43 (100%) 174 (99.4%) 
Saturated Fat 42 (97.7%) 174 (99.4%) 
Trans Fat 18 (41.9%) 140 (80.0%) 
 
Intake Differences Between Groups 
Comparisons between groups of nutrient intakes were done using independent t-
tests of the mean percent DRIs.  Cholesterol, vitamin A, D, E, K, C, thiamin, riboflavin, 
pantothenic acid, B-12, copper, and percent of recommended trans fats were log 
transformed to approach Normality.   The HIV+ group had a significantly lower mean 
percent DRI for fiber (-5.5%, P=0.023), folate (-17.3%, P=0.041), calcium (-11.9%, 
P=0.013), vitamin A (-19.2%, P=0.003), vitamin E (-10.5%, P=0.009), vitamin K (-
37.6%, P=0.038), vitamin C (-42.6%, P=0.003), thiamin (-25.45%, P=0.029), riboflavin 
  
(-42%, P=0.002), pantothenic acid (
phosphorus (-20%, P=0.033), magnesium (
P=0.044), potassium (-5.5%, P
calories from fat (8.1%, P
significantly lower % calo
Figure 4 summarizes the suboptimal micronutrient intake of the HIV+ group, and the 
differences from the control group.
 
 
Figure 4.  HIV+ Micronutrient Intake Deficiencies: Differences Between Groups in 
Mean % DRI intake.  
P-value 0.003 
 
 
 
 
 
 
-18.6%, P=0.009), copper (-18.2%, P
-16.5%, P=0.003), manganese (
=0.021).  The HIV+ group had significantly higher % 
=0.020) and % calories from trans fat (0.3%, P<0.001
ries from carbohydrate (-2.9%, P=0.014). See Figure 5 and 6.  
 
0.067 0.009 0.009 0.041 0.013 0.003
37
=0.048), 
-18.1%, 
), and 
 
 0.021 
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Figure 5. Differences Between Groups in Macronutrient Distribution.  
 
 
Comparisons to The American Heart Association Recommendations 
The intake of the HIV+ and the control group were compared to the AHA 
recommendations using independent t-tests for fiber and one-sample t-test for fat, 
saturated fat, trans fat, and cholesterol.  See Figure 6. 
The control group had significantly less fiber intake than the AHA 
recommendation of 14g per 1000 kilocalories (mean difference=-14.56g, P<0.001), 
significantly more saturated fat intake than the AHA 7% recommendation (mean 
difference=4.12%, P<0.001), and significantly more trans fat intake than the AHA 1% 
recommendation (mean difference=0.15%, P<0.001). Fat intake for the controls fell 
within the recommended range, but not significantly (-1.2%, P=0.128).  Cholesterol 
intake was less than the recommended intake, but not significantly (-36.98g, P=0.070). 
The HIV+ group had significantly less fiber intake than the AHA 
recommendation (mean difference= -15.7g, P<0.001). Fiber was log transformed to 
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approach normality.  Mean percent calories from saturated fat was significantly higher 
than the 7% recommendation (mean difference=4.55%, P<0.001).  Mean percent calories 
from fat was significantly higher than the 35% upper range recommendation (mean 
difference 1.02%, P=0.018).  Mean percent calories from trans fats was significantly 
greater than the AHA recommendation of 1% (mean difference=0.45%, P<0.001).  
Cholesterol intake was significantly within the recommended intake of 300mg 
(mean=254.9mg, P<0.001). 
Figure 6. Differences Between Mean % Intake of AHA recommendation.  
 
P-value b/w 
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0.023 0.020 <0.001 0.263 0.638  
P-value from 
recommenda
tion 
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<0.001 0.128* <0.001 <0.001 0.070* Control 
*Met AHA recommended intake 
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Nutrient Intake and Correlations with Subject Characteristics and HIV-factors 
Nutrient intake and associations with HIV + subject characteristics 
Nonparametric correlations (Kendall’s tau) were performed to find associations 
between BMI and nutrient intakes, as well as age and nutrient intakes, in the HIV+ group.  
As would be expected, calorie intake was positively associated with age (r=0.152, 
P=0.003).  BMI is negatively correlated with percent DRI of vitamin A (r=-0.135, 
P=0.008), vitamin D (r=-0.108, P=0.034), vitamin E (r=-0.179, P<0.001), riboflavin (r=-
0.201, P<0.001), thiamin (r=-0.184, P<0.001), niacin (r=-0.162, P=0.002), pantothenic 
acid (r=-0.146, P=0.004), vitamin B6 (r=-0.173, P=0.001), folate (r=-0.190, P<0.001), 
vitamin B12 (r=-0.129,P=0.012), magnesium (r=-0.229, P<0.001), iron (r=-0.122, 
P=0.017), zinc (r=-0.179, P<0.001), copper (r=-0.210, P<0.001), potassium (r=-0.110, 
P=0.032), and selenium (r=-0.163, P=0.001).   There was a positive correlation between 
age and intake of phosphorus (r=0.253, P<0.001), sodium (r=0.113, P=0.027), and fat 
(r=0.122, P=0.017). 
Nutrient intake differences between genders, in the HIV+ group, were compared 
using independent t-tests.  For the suboptimal micronutrient intake, Vitamins A, D, E, 
pantothenic acid, folate, and magnesium were log transformed to approach Normality. 
Potassium and calcium did not need to be log transformed.  Females had significantly 
lower mean % DRI for folate (-0.184%, P=0.004), pantothenic acid (-0.182%, P=0.000), 
vitamin D (-0.09%, P=0.002), calcium (-0.17%, P<0.001), potassium (-0.085%, 
P<0.001), and calories (-387 kcal, P<0.001). 
To determine significant differences in mean suboptimal nutrient intakes between 
races in the HIV+ group, one-way ANOVA and Bonferroni post-hoc comparisons were 
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performed for each nutrient.  Caucasians had significantly greater mean % DRI of 
vitamin D intake than African Americans (26.2%, P=0.027). Latinos had significantly 
lower mean percent fat intake from calories compared to blacks (-10.8%, P=0.003) and 
Caucasians (-10.1%, P=0.031). Mean percent DRI for calcium intake was significantly 
lower in African American than in Caucasians (-31.2%, P=0.017). 
Nutrient intake and CD4+ count correlations 
To determine if nutrient intake was associated with CD4+ counts, correlations 
were performed.  The current, nadir, and change in CD4+ counts were not normally 
distributed and could not be log transformed; therefore, Kendall’s Tau nonparametric 
correlations were performed. 
Amongst all HIV+ subjects, calorie intake was negatively correlated with the 
current CD4+ (r=-.116, P=0.024) and nadir CD4+ (r=-0.105, P=0.041). The percent of 
DRI of vitamin A was positively associated with nadir CD4+ count (r=0.102, P=0.047).  
The percent DRI zinc was positively associated with current CD4+ count (r=0.128, 
P=0.013), as was the percent DRI of riboflavin (r=0.120, P=0.019), and the percent DRI 
of magnesium (r=0.141, P=0.006).  
When looking at only those on ART, riboflavin intake was positively associated 
with CD4 nadir (r=0.129, P=0.033), as was B12 intake (r=0.122, P=0.044).  Current 
CD4+ was positively associated with magnesium (r=0.140, P=0.020) and zinc intake 
(r=0.188, P=0.050). 
When looking at those not on ART, there were no significant correlations with 
CD4+ counts. 
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For subjects on ART for greater than 6 months that have a viral load less than 
1000, there were no significant associations between nutrient intakes and CD4+ change. 
CD4+ nadir was positively associated with B12 intake (r=0.144, P=0.036) in these 
specific subjects, as it was in all subjects on ART.  Current CD4+ was positively 
associated with magnesium intake (r=0.148, P=0.030). Calorie intake was negatively 
associated with both current CD4+ (r=-0.153, P=0.025) and nadir CD4+ (r=-0.136, 
P=0.049).  No other significant correlations were found. 
Nutrient intake and viral load correlations in subjects not on ART 
In subjects not on ART, viral load was only significantly negatively correlated 
with protein intake (r=-0.296, P=0.046). 
Lipid Profiles 
When comparing fasting lipid levels to the healthy standards (TC <200mg/dL, 
LDL-C < 130mg/dL, HDL-C > 40mg/dL and triglycerides < 140mg/dL), both the control 
and HIV-infected groups were significantly within the healthy range.  Triglycerides and 
LDL-C were log transformed to normality for the control group.  Triglycerides were log 
transformed to normality for the HIV+ group. 
 
Table 7. Fasting Lipid Levels Compared to Healthy Standards 
One-Sample T-test 
 Standard 
(mg/dL) 
Mean 
Difference 
Sig. 95% CI 
HIV-Infected 
TC 200 -44.905 0.000 -50.81, -39.00 
LDL 130 -35.450 0.000 -39.40, -31.50 
HDL 40 3.988 0.001 1.59, 6.39 
TG 140 -56.018 0.000 -64.15, -47.89 
Controls 
TC 200 -49.326 0.000 -59.01, -39.64 
LDL 130 -41.140 0.000 -51.00, -33.28 
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HDL 40 11.163 0.000 7.16, 15.17 
TG 140 -81.442 0.000 -88.75, -74.13 
 
 
Table 8. Prevalence of Dyslipidemia: Subjects with High TC, LDL-C, TG, or Low 
HDL-C  
No. (%) Controls HIV+ 
TC 4 (3%) 21 (11.8%) 
LDL-C 4 (3%) 14 (7.9%) 
HDL-C 7 (5.3%) 78 (43.8%) 
TG 1 (0.8%) 16 (9%) 
 
 
There were no significant differences between groups for TC and LDL-C. See 
Table 9. HDL-C and triglycerides were not normally distributed and were log 
transformed to create a normal distribution.  Independent t-tests of the log 
transformations revealed significant differences between the HIV-infected and the control 
groups.  HDL-C was significantly lower in the HIV-infected group (-7.163mg/dL, 
P=0.001).  Triglycerides were significantly higher in the HIV-infected group 
(25.795mg/dL, P=0.001).  Differences within the HIV-infected group between those 
taking ART and those not taking ART are in Table 10.   
Table 9. Mean Lipid Profiles in Fasting State. 
Mean ± SD   
 
HIV+ (n=175) Controls (n=43) P-value 
Total Cholesterol (mg/dL) 155.29 ±38.929 150.67 ± 31.471 0.473 
LDL-Cholesterol (mg/dL) 94.66 ± 26.217 87.86 ± 28.779 0.138 
HDL-Cholesterol (mg/dL) 44.1 ± 15.923 51.16 ± 13.009 0.001 
Triglycerides (mg/dL) 84.35 ± 53.8 58.56 ± 23.757 0.001 
 
Table 10. Differences in Mean Serum Lipids Between HIV-infected on ART vs. Not 
on ART 
 ART Mean Std. Deviation P-value 
TC Currently taking ART 163.4959 38.90568 0.000 
Not currently taking ART 134.1702 30.33746  
LDL-C Currently taking ART 98.6885 25.01672 0.001 
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Not currently taking ART 84.4167 26.66325  
HDL-C Currently taking ART 47.1148 16.80132 0.000 
Not currently taking ART 36.0833 9.78673  
TG Currently taking ART 88.6311 58.77316 0.160 
Not currently taking ART 73.4792 36.69598  
 
Nutrient Intake and Lipid Profile Correlations 
Pearson’s correlation coefficient was used to calculate the strength and 
significance of correlations between the nutrients focused on by the AHA (fat, saturated 
fat, trans fat, cholesterol and fiber) and serum lipid measures (TC, LDL-C, HDL-C, TG).  
Variables were independent and any non-normal variables were log-transformed to 
approach Normality. 
The HIV-positive group results are in table 11.  There was a positive correlation 
between fiber intake and serum triglycerides (r=0.157, P=0.041) and trans fat intake and 
serum LDL-C (r=0.158, P=0.040).  There was a negative correlation between total fat 
intake and serum triglycerides (r=-0.170, P=0.027). 
The control group results are in table 12.  There was a positive correlation 
between cholesterol intake and serum triglyceride levels (r=0.315, P=0.040). 
Table 11. HIV+: Correlations Between Nutrient Intake and Lipid Profiles 
 Correlation TC LDL-C HDL-C Triglycerides 
Fiber (% of rec) r 0.097 0.001 0.116 0.157 
P-value 0.210 0.987 0.131 0.041 
Cholesterol (avg 
mg) 
r -0.019 0.066 -0.068 -0.080 
P-value 0.805 0.391 0.378 0.303 
% kcal from Fat r 0.033 0.067 0.060 -0.170 
P-value 0.672 0.383 0.438 0.027 
% kcal from SF r -0.038 -0.007 -0.030 -0.100 
P-value 0.623 0.923 0.702 0.193 
% kcal from Trans 
Fat 
r 0.115 0.158 -0.090 0.119 
P-value 0.136 0.040 0.245 0.122 
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Table 12. Controls: Correlations Between Nutrient Intake and Lipid Profiles 
 Correlation TC LDL-C HDL-C Triglycerides 
Fiber (% of rec) r -0.117 -0.205 0.148 0.001 
P-value 0.455 0.187 0.344 0.993 
Cholesterol (avg 
mg) 
r 0.077 0.080 -0.064 0.315 
P-value 0.623 0.608 0.685 0.040 
% kcal from Fat r 0.079 0.114 -0.078 -0.049 
p-value 0.616 0.468 0.619 0.753 
% kcal from SF r 0.101 0.152 -0.153 0.163 
P-value 0.520 0.332 0.326 0.296 
% kcal from Trans 
Fat 
r -0.014 0.009 0.033 -0.144 
P-value 0.931 0.954 0.833 0.356 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
Suboptimal Micro- and Macronutrient Intake in HIV-infected Subjects 
Micronutrients 
Diet was analyzed using at least two, nonconsecutive, 24-hour food recalls, which 
is recommended by the IOM when analyzing dietary intake.47  This study showed the 
intake of 61%-100% of the HIV-infected youth did not meet dietary guidelines for 
vitamins A, D, E, pantothenic acid, folate, calcium, magnesium, potassium, and sodium. 
Mean intake for these nutrients was significantly lower, or in the case of sodium higher, 
than the DRI.   
Most studies used different methodologies to determine adequate nutrient intake, 
therefore caution must be taken before making direct comparisons between studies.  
Kruzich and colleagues42 also found suboptimal vitamin A and E intake among 13-38% 
of HIV-infected adolescents; however, the less stringent Estimated Average Requirement 
(EAR) was used to assess adequate nutrient intake.  The EAR is the nutrient intake 
amount that is expected to meet the needs of only half of the healthy population.28  The 
IOM47 recommends comparing intake to the EAR for the general population. However, 
the World Health Organization recommends that children and adults with HIV meet at 
least the RDA;16 therefore, our study compared mean intake of nutrients to the RDA.  
Zinc intake did not meet requirements in the Kruzich and colleagues’ study,42 but that 
was not the case in this study with mean zinc intake reaching 108% of the DRI for the
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HIV+ group.  Zuin et al.41 only assessed intake of 4 nutrients using 3-day food diaries, 
but similarly found that calcium intake was well below the RDA in HIV-infected 
children.  They also found poor dietary iron intake, which was not supported by our 
study. 
Vitamin D, calcium, potassium, and vitamin E were the micronutrients consumed 
in the lowest amounts (HIV+: mean <60% of the DRI), and sodium intake was 
exceedingly excessive (HIV+=236% of AI).  Proper intake of these micronutrients is vital 
for optimal health. Vitamin D and calcium are important for proper bone growth in our 
adolescent population,49 and research suggests that low serum vitamin D is associated 
with CVD risk factors in US children and adolescents.50  Due to the already increased 
risk factors for CVD in the HIV-infected population,13,38,43,44 vitamin D intake is of even 
greater importance.  In fact, studies on HIV-infected adults have shown associations 
between vitamin D status and markers for CVD, as well as immune function.51,52  
Consuming adequate potassium and staying within recommendations for sodium intake 
can help regulate blood pressure, an important factor in reducing CVD risk.12  
Furthermore 95% of our study population was African American, which is a race 
particularly sensitive to the effects of these key nutrients on blood pressure and 
cardiovascular problems.12 The effects of these nutrients on the blood pressure of this 
study population should be explored in future studies. Vitamin E is important for immune 
function42 and is an antioxidant that protects against oxidative damage, which is 
increased in HIV-infected individuals.30 Stephensen et al.30 concluded that HIV-infected 
youth have a greater need for vitamin E, as well as C, yet our HIV-study population is 
only consuming 54% of the vitamin E DRI for healthy individuals.  
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Macronutrients 
The recommendation on the macronutrient breakdown of protein, carbohydrate 
and fat does not differ for the HIV-infected individual.4,16,31,36 Protein and carbohydrate 
intake was sufficient and fell within the recommended AMDR for both groups.  Past 
research shows consuming adequate protein is not a concern for HIV-infected youth.  The 
dietary intake of all of the children studied by Zuin and associates41 exceeded the RDA 
for protein.  Henderson and colleagues4 found the mean protein intake was 200% of the 
RDA among 38 HIV+ children, and Sharma et al.32 found that mean protein intake 
ranged between 160-378% of the RDA in 126, HIV-infected 3-20 year olds.   
The HIV-infected youth in this study had a mean percent fat intake from 
kilocalories that exceeded the recommendations, while the control group’s intake 
remained within the AMDR.  In Brazil, Tremeschin and colleagues13 also found fat intake 
exceeded the AMDR (38.5% of kilocalories), but did not find any difference between the 
HIV-infected youth and the controls.  Mean percent fat from kilocalories for the HIV-
infected group in our study was significantly above the AMDR range maximum of 35%. 
Intake Differences Between HIV-infected and Healthy Subjects 
Analysis of the food recalls also shows HIV-infected youth present with poorer 
micro- and macronutrient intake compared to healthy controls despite similarities in 
caloric intake. The HIV+ group had significantly lower dietary folate, calcium, vitamin 
A, E, K, C, thiamin, riboflavin, pantothenic acid, copper, phosphorus, magnesium, 
manganese, and potassium intake.  Some researchers35 believe that adequate intake of 
these vitamins and minerals contribute to the slowing of HIV progression due to their 
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antioxidant effects and ability to reduce oxidative stress.  Oxidative stress is considered 
as an important factor in the pathogenesis of the HIV disease.   
Furthermore, the HIV+ group had significantly higher percent calories from fat 
and lower percent calories from carbohydrate compared to the control group.  
Alternatively, most studies did not find differences in nutrient intakes between the 
infected and the healthy children and adolescents.4,13,32,41,42  The REACH study7 did find 
that macronutrient intake was poorer in the HIV-positive group of adolescents due to 
higher intakes of fat, saturated fat and cholesterol compared to the non-infected controls.   
Nutrient Intake Associations with HIV-Related Factors 
Overall, research suggests that sufficient micronutrient status may contribute to 
improved immune status and survival in HIV-infected individuals. Baum and 
colleagues24 found that as serum vitamin A, B-12, and zinc status improved, CD4+ cell 
counts increased in adult HIV-infected males.  We found similar associations with the 
intake of these nutrients in our cohort of male and female youth. Percent DRI of vitamin 
A was positively correlated with nadir CD4+ count, and the percent DRI for zinc was 
positively associated with current CD4+ count, amongst all HIV-infected subjects.  
Dietary intake of riboflavin and magnesium was also positively associated with current 
CD4+ count, although similar correlations were not found in other studies.  When we 
analyzed only subjects on ART medication, B-12 intake was also associated with CD4+ 
nadir, which supports the findings by Baum and colleagues.24  Other studies also found 
similar associations between HIV progression biomarkers and serum B-12.26  
Furthermore in one of the few studies looking at children, Steenkamp and colleagues19 
found ART naïve children with abnormally low serum levels of zinc and vitamin A had 
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significantly lower CD4+ cell counts and higher viral loads.  While analysis of our entire 
HIV cohort saw associations with zinc and vitamin A intake and CD4+ counts, in our 
subjects not on ART, viral load was only significantly negatively correlated with dietary 
protein intake. Therefore, we did not find evidence that adequate micronutrient intake 
was able to keep viral load down when ART medication was not being used. On the other 
hand, adequate protein intake in those HIV-infected youth not on ART may be important. 
Unfortunately, all aforementioned studies assessed serum levels and not dietary 
intake, but it is worth noting similarities in correlations.  Further investigation is 
warranted to determine whether nutrient intake data correlate with plasma nutrient 
concentrations in HIV+ youth and the potential impact of nutritional status on immune 
function and HIV progression.  In studies of HIV-infected adults, correlations were found 
between serum concentrations and dietary intake of B-12,26 vitamin A, and zinc,24 which 
may be relevant for the associations found in our study. 
Few studies have looked at correlations between dietary intake of nutrients and 
HIV-factors.  In a study27 of HIV-infected men that evaluated dietary intake, the 
researchers found that increased intake of zinc was associated with the progression of 
HIV and decreased CD4+ cell count, which we did not find.  Kruzich and colleagues42 
found no associations between nutrient intakes and CD4+ cell counts.   
In our study, kilocalories were negatively correlated with the current and nadir 
CD4+, suggesting that as our subjects increased their dietary caloric intake their immune 
status worsened.  While it was a weak correlation, it was still significant.  Previous 
studies looking at caloric intake associations found no significant associations with CD4 
category, progression to AIDS,27 or mortality.21  However, these previous studies used 
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semi quantitative food frequency questionnaires and were done prior to the introduction 
of ART.  The IOM recommends using at least two, 24-hour recalls on nonconsecutive 
days to assess usual intake,47 as opposed to food frequency questionnaires, which is one 
of the strengths of our study.  Likewise, we also saw a higher BMI was associated with 
poorer intake of most nutrients, which hint at poor diet choices among those with higher 
BMIs, since calorie intake showed no association with BMI.  No additional regression 
analysis was performed due to the weak association, and to our knowledge this has not 
been assessed in prior studies.  Additional studies should investigate this association. 
When looking only at subjects on ART for greater than 6 months that have a viral 
load of less than 1000, there were no significant associations between nutrient intakes and 
CD4+ change.  One might conclude that improved dietary intake did not contribute 
towards improvements in CD4+, or HIV-status; however, this information would be more 
useful if the study assessed nutrient intake and CD4+ count together at different points in 
time.  This study only looked at average nutrient intake over the year and associations 
with CD4+ change that took place prior to the collection of food recalls. 
 
CVD Risk Factors 
Chronic infection and inflammation in HIV-infected individuals seems to increase 
atherosclerotic processes, including lipid abnormalities, lipodystrophy, and vascular 
structural changes in children infected with HIV, which are critical risk factors for 
CVD.13,38,43,44   Our cohort of youth was less affected by lipodystrophy and dyslipidemia. 
Waist-to-hip ratios, one indicator of lipodystrophy, in our HIV-infected cohort were 
similar to healthy controls.  However, lipodystrophy is better diagnosed by fat 
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redistribution, for instance visceral fat accumulation, and would be better assessed by 
looking at changes in waist-to-hip ratios over time.13, 38  Furthermore, assessment of 
lipodystrophy is complicated due to growth;38 therefore, any assessment done in a youth 
cohort would need to be treated with caution.   
Mean lipid profiles were within healthy ranges for both groups, suggesting 
dyslipidemia is not a concern in this population.  However, the HIV-infected group did 
have significantly higher mean triglycerides and significantly lower mean HDL-C.  The 
prevalence of dyslipidemia among the HIV-infected youth was higher than healthy 
controls with 11.8% having high TC (controls=3%), 7.9% with high LDL-C 
(controls=3%), 9% with high TG (controls=0.8%), and 43.8% with low HDL-C 
(controls=5.3%).  Other studies found similar results, including a study of a cohort of 94 
children ages 1 through 18 that found 62% of the subjects on PI had dyslipidemia.44  In a 
London study,10 it was determined that 10% of children on ART required hyperlipidemia 
intervention.  In contrast, Tremeschin and colleagues13 found no statistical differences, 
among 4-17 year olds, in hyperlipidemia between the HIV-infected and control groups, 
aside from increased serum triglycerides in those subjects on PI.  Our study did not assess 
differences in lipid values between those on PI versus other ART drugs, but did similarly 
find the HIV-infected group had higher triglyceride levels compared to the controls.  
In the current study, TC and LDL-C was significantly higher in those HIV-
infected youth on ART compared to those not currently on ART.  Surprisingly, HDL-C 
was also significantly higher in those HIV-infected youth on ART, which suggests HDL-
C may be offsetting some of the negatives associated with higher TC and LDL-C in this 
group.   
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Several risk factors for CVD were studied in 83 HIV-infected children in 
London.43 Similar to our study, mean serum triglycerides were significantly higher and 
mean serum HDL-C was significantly lower in the HIV-infected children compared to 
the controls.  This study also looked at vasculature in the groups and determined that the 
common carotid artery’s IMT was significantly higher in the HIV infected children and 
FMD of the brachial artery was lower, showing this groups increased risk for 
atherosclerosis and CVD. 
Considering the mean BMI, our HIV-positive group would not be categorized as 
overweight or obese, which is in contrast to findings of other studies in which the 
majority of the cohort was found to be overweight.7  This suggests that our cohort may be 
in less danger of developing risk factors associated with CVD, and may also explain why 
mean lipid values fell within healthy standards.   
Intake Compared to Recommendations for a Heart Healthy Diet 
Given the research showing HIV-infected individual’s increased risk factors for 
CVD, it is important to know whether HIV-infected youth follow a heart healthy diet, and 
if the intake of certain lipids and fiber influence nutritional markers of CVD.  Research38 
suggests HIV-infected individuals with hyperlipidemia should limit fat intake to 30% of 
kilocalories, and the AND36 suggests limiting trans fat, saturated fat and cholesterol 
intake to similar levels recommended by the AHA in these individuals.  The AHA 
recommends total fat intake to be between 25 and 35% of total calories, saturated fat to 
be less than 7% of total calories, trans fats to be less than 1% of total calories, cholesterol 
to be less than 300mg per day, and to consume 14g of fiber per 1000 calories consumed 
per day, to reduce the risk of CVD.19 
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Our study revealed HIV-infected youth have poorer dietary intake compared to 
healthy youth due to greater intake of nutrients associated with increased risk of 
cardiovascular disease (i.e. fat and trans fat).  The HIV-infected youth in this study had a 
mean percent fat intake from kilocalories that exceeded the AHA recommendation.  In 
Brazil, Tremeschin and colleagues13 also found fat intake exceeded the 35% 
recommendation. The same study found both HIV-infected and controls had excess 
intake of saturated fats, which is similar to what we found with both groups significantly 
exceeding the 7% recommendation and no significant difference between the groups 
(HIV+=11.55%; Controls=11.12%). Sharma et al.32 also used 24-hour recalls to find their 
HIV-infected youth cohort had excess mean intake of saturated fat at greater than 12% of 
kilocalories.   
Furthermore, our study revealed percent calories from trans fats significantly 
exceeded the 1% AHA recommendation in both HIV+ and controls, but the HIV+ group 
had significantly higher intake than the control group.  Limiting saturated and trans fatty 
acids in the diet is associated with a lower risk of CVD, mostly due to its effects on LDL-
C.12   
Moreover, all but one subject between both groups did not meet fiber 
recommendations, and mean intake of fiber in both groups was significantly lower than 
the AHA’s recommendation of 14g/1000kcal. The HIV+ group had significantly worse 
fiber intake than the control group.  Increased dietary fiber, both insoluble and soluble, 
has been linked with lower CVD risk as well as decreased progression to CVD in high-
risk individuals, such as the HIV-infected population.12  In contrast to the REACH study,7 
dietary intake of cholesterol was within healthy recommendations for both groups. 
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Associations Between Diet and Lipid Profiles in HIV-infected Subjects 
Pearson’s correlation coefficients showed few weak associations between lipid 
profiles and intake of nutrients generally associated with altered serum lipids (fat, 
saturated fat, trans fat, cholesterol and fiber).  It did show a positive correlation between 
fiber and serum triglycerides, which is unusual, but it was a very weak correlation and 
may be due to the majority of fiber intake being insoluble fiber; soluble fiber is generally 
associated with lower LDL-C.  This study only looked a total fiber, and did not 
distinguish between soluble and insoluble.   
In contrast to a study of adults with HIV by Barrios and colleagues,11 we did not 
find a correlation between percent calories from fat and serum lipids in our cohort of 
HIV-infected youth, aside from a weak, positive relationship between trans fat intake and 
LDL-C.  Surprisingly, as percent calories from fat increased, triglycerides decreased, but 
this was only a very weak association, and could not be explained. Shah et al.40 also 
looked at correlations between lipid levels and specific nutrients and found trans fats 
were positively correlated with triglyceride levels.  Moreover, soluble fiber intake was 
negatively correlated with total cholesterol, triglycerides, and non-HDL cholesterol.  
They did not find any associations between lipid levels and cholesterol and saturated fat 
intake.  All previous studies assessing these correlations were in HIV-infected adults, and 
thus may not be applicable to our population.  To our knowledge, these associations have 
not previously been explored in HIV-infected youths.  
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Study Limitations 
While the relatively large sample size was a strength for this study, there were 
limitations.  Often limitations arise when using 24-hour recalls, as they do with most 
methods used for assessing dietary intake. There was likely over- or under-reporting of 
food intake when collecting the 24-hour recalls from the youth or caregiver, and an 
evaluation of the over- or under-reporting would be valuable in determining the validity 
of the recalls.  Also, some recalls were obtained by phone and may not have been as 
accurate as those obtained in the clinic.  Additionally, the control group had fewer 
average recalls per subject, which could be a limitation since most of the controls only 
had 2 recalls while most of the HIV-infected youth had 4 recalls completed.  This 
difference in recalls obtained from subjects was likely due to the ease of retrieving a 24-
hour dietary recall from HIV-infected subjects since research investigators saw them in 
the clinic more for often for appointments.  
The cross-sectional study design was also a limitation in that no cause and effect 
could be established from the associations found.  Analysis of HIV-related factors and 
lipid levels with nutrient intakes in a sequential manner may have provided a causal link. 
Furthermore, the BLOCK FFQ that was collected with the data was not used to 
validate the 24-hour recalls; however, FFQs have limitations as well in that it does not 
capture intake at different periods of time.   
Moreover, the demographics of our study population may be a limitation.  The 
results from the study may not be extrapolated to the entire pediatric population, as 95% 
of the subjects were African American.  While most of the HIV diagnoses in the U.S. are 
African Americans, it is only 44%,1 and as we saw there were differences in nutrient 
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intake between different races.  Also, there was a wide age range among our subjects, 
which makes it more difficult to generalize results to a certain group.  Analyzing the data 
among different age groups such as children, adolescents, and early adulthood, would be 
valuable. 
Conclusion 
While the HIV-infected youth in our study are consuming similar kilocalories to 
those without HIV, they are making poorer food choices, which may ultimately lead to 
poorer health outcomes.  Unfortunately, HIV-infected youth have greater micronutrient 
needs in order to maintain immune status and are at greater risk for CVD.  Despite these 
known issues associated with the disease, diet is a modifiable factor that these patients 
may be able to control to alter their health status in the long run.  Currently nutritional 
needs are not being met and nutrition counseling is needed in this population to ensure 
nutrient dense foods are consumed.  This study supports suggestions made by the AND 
as well as other studies that advise nutrition counseling is of utmost importance in HIV-
infected youth.  Providing nutrition counseling to youths, early on in the disease process, 
is likely to optimize health.  While some may think supplements can support 
inadequacies in micronutrient intake, the World Health Organization16 suggests that an 
adequate diet is the best method for meeting nutrient needs in HIV-infected individuals 
due to past research on supplementation.  Medical nutrition therapy is known to improve 
immune status, progression of HIV, and risk of mortality.35    Furthermore, nutrition 
education must be customized to the HIV-infected individual depending on age, race and 
sex, as differences between these groups were seen for suboptimal nutrient intakes. To 
our knowledge this was the first study to comprehensively study nutrient intake and 
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associations with lipid profiles as well as HIV-related factors in HIV-infected youth.  I 
believe this study offers insight into the dietary intake of this population and possible 
associations with nutrients and immune status.  And although poor diet was not reflected 
in serum lipid profiles, the increased dyslipidemia in the HIV-infected youth may, over 
time combined with poor diet, contribute towards CVD.  Based on these results, 
longitudinal, randomized control trials should be performed to determine the impact of 
nutrition counseling and specialized diets on the health outcomes of youth with HIV. 
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ABSTRACT 71 
 72 
Background: Few studies have evaluated habitual nutrient intake among HIV-infected 73 
youth in the United States, even though diet may influence disease progression and 74 
chronic complication risk.  75 
Objective: This study determined micro- and macronutrient intake in HIV-infected 76 
youth, and investigated relationships among nutrient intake, demographics, lipid profiles, 77 
and HIV-related factors.  78 
Design: HIV-infected subjects and healthy controls 1-25 years old were prospectively 79 
enrolled. Concomitant demographic, clinical and laboratory data were collected. Nutrient 80 
intake was assessed via 24-hr dietary recalls performed every 3 months for one year, 81 
analyzed with NDS-R software, and compared to Dietary Reference Intakes (DRIs) and 82 
Acceptable Macronutrient Distribution Ranges (AMDRs).  83 
Results: Subjects with ≥2 food recalls were analyzed (175 HIV+; 43 controls). Groups 84 
were similar in age, race, sex, body mass index, and kilocalorie intake. Both groups did 85 
not meet DRI for several micronutrients. HIV+ subjects had lower %DRI than controls 86 
for vitamins A, E, pantothenic acid, magnesium, calcium, folate and potassium. Percent 87 
kilocalories from fat was above normal and higher in HIV+ patients. Caloric intake was 88 
negatively correlated with current and nadir CD4 counts. Zinc, riboflavin, and 89 
magnesium %DRI were positively associated with current CD4+ count. In HIV+ subjects 90 
not on antiretroviral therapy, HIV-1 RNA levels were negatively correlated with protein 91 
intake.   92 
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Conclusions: HIV+ youth have inadequate intake of several essential nutrients and 93 
poorer dietary intake compared to controls. Intake of some nutrients was associated with 94 
HIV-related factors. Further investigation is warranted to determine the impact of 95 
nutrition on HIV progression and chronic complication risk in this population.   96 
 97 
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 111 
 112 
 113 
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INTRODUCTION 116 
According to the Centers for Disease Control and Prevention (CDC), there were 117 
almost 43,000 new diagnoses of HIV infection in the United States in 2009, with 20% 118 
between the ages of 0 and 24 years (1).  Nutritional deficiencies are common among 119 
people with HIV, including HIV-infected youth (2-8).  In HIV-infected adults, nutritional 120 
deficiencies have been shown to affect immune status, disease progression and mortality 121 
(7-15).   122 
With the advent of highly-active antiretroviral therapy (HAART), concerns over 123 
nutritional deficiencies in the HIV-infected population have shifted from AIDS wasting 124 
syndrome, growth stunting, and chronic diarrhea to newly-described long-term 125 
complications associated with chronic HIV infection secondary to increased 126 
inflammation, oxidative stress, and immune activation (6-7, 16-23). For example, HIV-127 
infected individuals have an increased risk of cardiovascular disease (CVD) that have 128 
been shown to be associated with nutritional deficiencies in other populations, as well as 129 
within the HIV population (24-26). In addition, HIV-infected individuals are at an 130 
increased risk of lipid abnormalities and metabolic syndrome, which have been shown to 131 
improve with dietary intervention in the general population (18,22-22,24, 26-28).  132 
Like HIV-infected adults, increased risk for CVD, and metabolic abnormalities 133 
occurs among HIV-infected youth (18,22,29-32).  Combined with a rising prevalence of 134 
obesity in this population and higher nutritional risk due to growth and development 135 
demands, nutritional deficiencies in this population are particularly alarming (29,33).  136 
Moreover, chronic immune activation and increased oxidative stress in HIV-infected 137 
youth may result in increased nutrient needs beyond the recommended intakes (6,20,34), 138 
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while those individuals with hyperlipidemia or metabolic dysfunction may need to 139 
decrease their fat, trans fat, saturated fat, and cholesterol intake (30,36).  To date, 140 
however, few studies have investigated nutritional intake among HIV-infected youth, 141 
despite the serious implications for HIV disease progression and complication 142 
development in this population (2,6,17,29, 36-38).  And, notably, the few studies that 143 
have investigated this important topic used less stringent methods than what is 144 
recommended for nutrient intake assessment and/or only explored a few micronutrients. 145 
Thus, the primary objective of this study was to comprehensively evaluate the 146 
micro- and macronutrient intake in HIV-infected youth.  Secondary objectives included 147 
(1) to compare the nutrient intake in HIV-infected youth to that of current intake 148 
recommendations, (2) to compare the nutrient intake in HIV-infected youth to that of 149 
healthy controls, (3) to assess the associations between dietary intake and serum lipid 150 
levels, and (4)to determine if nutrient intake is associated with HIV-related variables. 151 
 152 
METHODS 153 
Study Population 154 
All patients between the ages of 1-25 years old with documented HIV-1 infection 155 
enrolled at the Ponce Youth HIV Clinic of the Grady Health System in Atlanta, GA, USA 156 
were eligible for this study.   Participants were recruited over a 10-month period of time 157 
while they were at the clinic for their regular HIV monitoring visits. Over 95% of 158 
approached patients consented to study participation.   159 
 Controls were recruited with advertisement flyers hung in the HIV clinic and by 160 
word of mouth, and selected so that the overall group matched the HIV-infected subjects 161 
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in age, sex, and race.  Healthy controls included relatives of the hospital staff, relatives of 162 
HIV-infected patients, and HIV-negative patients seen at the clinic. Controls were 163 
eligible if they self-reported to be free of chronic disease and had no recent or current 164 
infection.  Potential subjects ≥13 years of age were screened for HIV infection before 165 
enrollment with OraQuick Advance Rapid HIV Test (OraSure Technologies, Inc, 166 
Bethlehem, PA, USA).  Controls <13 years of age were assumed HIV-uninfected unless 167 
they were considered at high-risk for having or contracting HIV.  Exclusion criteria for 168 
controls were the same as for the infected group.   169 
All parents or legal guardians and subjects ≥18 years of age provided written 170 
informed consent to participate in the study, and those subjects 17 years of age signed the 171 
written consent along with their parent or legal guardian.  Subjects 6-10 years old gave 172 
verbal assent and those 11-16 years gave written assent.  The Institutional Review Boards 173 
of Emory University and Grady Health Systems approved the study, and all ethical 174 
principles of the institutions were followed throughout the study.   175 
 176 
Study Design 177 
Each subject underwent anthropometric, clinical, laboratory, and nutritional 178 
intake assessments at enrollment. Subjects were then followed prospectively and one 179 
additional nutritional intake assessment was obtained per subject for each season of the 180 
year during routine clinic visits or by telephone interview.  Only subjects with ≥2 181 
nutritional assessments obtained during different seasons were included in the study. All 182 
nutritional intake assessments and data entry were performed by registered dietitian-183 
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trained investigators and were overseen by registered dietitians. 184 
 185 
Nutritional Assessments  186 
Nutritional assessments were obtained for each season of the year by means of a 187 
24-hour diet recall in order to capture seasonal changes in dietary intake as well as day-188 
to-day variation in diet.  Each subject reported food intake over the last 24 hours.  The 189 
amounts were entered into Nutrition Data System for Research (NDS-R).  NDS-R is a 190 
dietary analysis program designed for the collection and analysis of 24-hour dietary 191 
recalls and provides a detailed analysis of macro- and micro-nutrient intake in units per 192 
day. Subjects had to have ≥2 nonconsecutive, 24-hour food recalls to be included in the 193 
analysis, as per the Institute of Medicine (IOM) recommendations for dietary intake 194 
analysis (39). 195 
Nutritional status was assessed using Dietary Reference Intakes (DRIs), which are 196 
the nutrient reference values derived from years of scientific research (40-41). 197 
Micronutrient intake was compared to the Recommended Dietary Allowance (RDA) or 198 
the Adequate Intake (AI), if no RDA existed for the nutrient. Individual recalls were 199 
assigned to an IOM life stage group, based on the subject’s gender and age on the day of 200 
the assessment. Due to collection of recalls taking place over time, subjects could have 201 
multiple life stage groups and multiple DRIs for one micronutrient; therefore, percent 202 
DRIs were calculated for each recall for each nutrient and subsequently averaged for each 203 
subject. Thus, percent DRI was used for all micronutrient analysis. A total of 22 204 
micronutrients were analyzed.  205 
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Mean macronutrient intake was compared to the Acceptable Macronutrient 206 
Distribution Ranges (AMDR). Fat, saturated fat, trans fat, cholesterol and fiber intake 207 
were compared to the recommendations of the American Heart Association (AHA) for 208 
the general population (total fat intake:25-35% of total calories; saturated fat: <7% of 209 
total calories; trans fats: <1% of total calories; cholesterol: < 300 mg per day; fiber: 14g 210 
per 1000 calories consumed per day)(26).   Normal lipoprotein profile levels were 211 
considered 200 mg/dL, 130 mg/dL, 40 mg/dL, and 140 mg/dL for total cholesterol (TC), 212 
low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-213 
C) and triglycerides (TG), respectively (2,28). 214 
Clinical Assessments 215 
Clinical measurements included weight, height, and waist and hip measurements 216 
(with standardized measurements based on procedure recommendations from the 217 
Metabolic Study Group of the AIDS Clinical Trials Group). All HIV-infected subjects 218 
and controls (or guardians) completed questionnaires in order to obtain relevant 219 
demographic and medical information (including vitamins and supplements). An 220 
extensive chart review was conducted for the HIV+ subjects, including detailed 221 
information on time of HIV diagnosis, past and current medical diagnoses, antiretroviral 222 
therapy (ART) use, and CD4 cell count nadir.  223 
Laboratory Assessments  224 
Lipoprotein profiles were obtained after at least an 8-hour fast. CD4 cell counts 225 
and HIV-1 RNA were obtained from the HIV-infected subjects.  226 
Statistical Analysis 227 
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 Demographics, clinical characteristics, and laboratory parameters are described by 228 
HIV status. Continuous measures are described by means/standard deviations, and 229 
nominal variables are described with frequencies/percentages.  Variables that were not 230 
normally distributed were log transformed and parametric tests were performed.  If the 231 
variables were not normally distributed after log transformations, non-parametric tests 232 
were used for analysis.  233 
 Statistical tests used to make group comparisons and to compare variables to 234 
standards included: Chi-squared for categorical variables, one-sample and independent t-235 
tests for normally distributed means, and Mann-Whitney U test for non-normally 236 
distributed means.  237 
 One-way analysis of variance (ANOVA) and Bonferroni post-hoc comparisons 238 
were used to determine differences in nutrient intakes between races. Pearson’s 239 
correlation coefficient or Kendall’s Tau were used to investigate associations between 240 
nutrient intake and variables of interest. A P-value <0.05 was considered significant. All 241 
analyses were carried out using SPSS 18.0.  242 
 243 
RESULTS 244 
Study Population 245 
175 HIV-infected subjects and 43 healthy controls were included in the analysis.  246 
Subject characteristics are summarized in Table 1.  Groups were matched for age, race, 247 
sex, body mass index (BMI), and waist-to-hip ratio. The prevalence of dyslipidemia was 248 
higher in the HIV+ group compared to controls (TC=11.8% vs. 3%; LDL-C=7.9% vs. 249 
3%; HDL-C=43.8% vs. 5.3%; and TG=9% vs. 0.8%).  Mean HDL-C was significantly 250 
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lower in the HIV-infected group and mean triglycerides were significantly higher in the 251 
HIV-infected group. No significant differences existed between groups for TC and LDL-252 
C.  253 
Dietary Intake, Comparison to Standards, and Between-Group Differences 254 
Recalls that were obvious outliers (<500 kilocalories or >5000 kilocalories in one 255 
24-hour period) were excluded from the analysis.  A total of 674 24-hour recalls were 256 
analyzed.  558 recalls were analyzed for the HIV+ group (mean = 3.2 recalls per subject): 257 
75 subjects with four recalls (43%), 58 subjects with three recalls (33%), and 42 subjects 258 
with two recalls (24%).  The control group had 113 recalls analyzed (mean = 2.6 recalls 259 
per subject): 7 subjects had four recalls (16%), 13 subjects had three recalls (30%), and 260 
23 subjects had two recalls (53%).   261 
Mean (standard deviation (SD)) intake for the HIV+ group was 1953.9 ± 610.87 262 
kilocalories, and 1990 ± 540.8 kilocalories for the control group (P = 0.723).   263 
Mean percentage of DRI intake of all micro- and macronutrients analyzed for the 264 
HIV+ and control groups are presented in Table 2 and Figure 1.  For the HIV-infected 265 
group, mean micronutrient intake was less than 100% of the DRI for vitamin A, vitamin 266 
D, vitamin E, pantothenic acid, folate, calcium, magnesium, and potassium (all P < 267 
0.001), with a prevalence of suboptimal intake at 82%, 99%, 93%, 73%, 61%, 93%, 87%,  268 
and 100% of subjects, respectively.  Ninety-nine percent of HIV-infected subjects 269 
consumed greater than the recommended DRI for sodium with the mean intake 270 
significantly greater than the DRI (P < 0.001).  For the controls, micronutrient intake was 271 
less than 100% of the DRI for vitamin A, vitamin D, vitamin E, calcium, magnesium, and 272 
potassium, and greater than the recommended DRI for sodium (all P < 0.001) with a 273 
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prevalence of suboptimal intake at 67%, 95%, 93%, 86%, 74%, 100%, and 100% of 274 
subjects, respectively.   275 
Among nutrients that were consumed in sufficient amounts within the HIV+ 276 
group, the HIV+ group nonetheless had a significantly lower percent DRI compared to 277 
controls for vitamin K (-37.6%, P = 0.038), vitamin C (-42.6%, P = 0.003), thiamin (-278 
25.45%, P =  0.029), riboflavin (-42%, P = 0.002), copper (-18.2%, P = 0.048), 279 
phosphorus (-20%, P = 0.033), manganese (-18.1%, P = 0.044).  280 
Mean percentage of calories from carbohydrate and protein fell within the AMDR 281 
for both groups.  Fat intake significantly exceeded the AMDR only for HIV-infected 282 
subjects (P = 0.018) (Figure 2). Compared to AHA recommendations, both groups had 283 
significantly less fiber intake and greater percentage of calories from saturated fat and 284 
trans fat, but normal cholesterol intake. The HIV+ group had significantly higher % 285 
kilocalories from fat and trans fat, and significantly lower % kilocalories from 286 
carbohydrate (-2.9%, P = 0.014) compared to the control group, but no difference in 287 
protein intake (P = 0.177). 288 
Within the HIV-infected group, females had significantly lower calorie intake (-289 
387 kcal, P < 0.001) and mean percent DRI for folate (-0.184%, P = 0.004), pantothenic 290 
acid (-0.182%, P = 0.000), vitamin D (-0.09%, P = 0.002), calcium (-0.17%, P < 0.001), 291 
and potassium (-0.085%, P < 0.001). African Americans had a lower percent DRI of 292 
vitamin D (-26.2%, P = 0.027) and calcium intake (-31.2%, P = 0.017) than Caucasians. 293 
Latinos had significantly lower percent fat intake from calories compared to African 294 
Americans (-10.8%, P = 0.003) and Caucasians (-10.1%, P = 0.031). 295 
 296 
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Associations Between Nutrient Intake and Serum Lipid Levels  297 
Within the HIV-infected group, there was a positive correlation between trans fat 298 
intake and serum LDL-C (r = 0.158, P = 0.040), as well as between fiber intake and 299 
serum triglycerides (r = 0.157, P = 0.041).  There was a negative correlation between 300 
total fat intake and serum triglycerides (r = -0.170, P = 0.027).  In the control group there 301 
was a positive correlation between cholesterol intake and serum triglyceride levels (r = 302 
0.315, P = 0.040).   303 
 304 
Associations Between Nutrient Intake and HIV-Related Factors  305 
Age was positively associated with intake of calories, phosphorus, sodium, and fat 306 
(Table 3).  Body mass index was negatively correlated with percent DRI of vitamin A, 307 
vitamin D, vitamin E, riboflavin, thiamin, niacin, pantothenic acid, vitamin B6, folate, 308 
vitamin B12, magnesium, iron, zinc, copper, potassium, and selenium.     309 
Within the HIV-infected group, calorie intake was negatively correlated with 310 
current CD4+ cell count and nadir CD4+ cell count. The percent of DRI for vitamin A 311 
was positively associated with nadir CD4+ cell count count.  The percent of DRI for zinc, 312 
magnesium, and riboflavin was positively associated with current CD4+ cell count. 313 
Among HIV-infected subjects currently on ART,  riboflavin and B12 intake was 314 
positively associated with CD4+ cell count nadir.  Current CD4+ cell count was 315 
positively associated with magnesium and zinc intake. For subjects on ART for >6 316 
months with an HIV-1 RNA <1000 copies/mL, there were no significant associations 317 
between nutrient intake and change in CD4+ cell count after starting ART (current-nadir 318 
CD4). 319 
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There were no significant correlations with CD4+ cell counts among those 320 
subjects currently not on ART.  However, HIV-1 RNA was negatively correlated with 321 
protein intake (r = -0.296, P = 0.046). 322 
 323 
DISCUSSION 324 
This study showed that the nutrient intake in HIV-infected youth did not meet 325 
dietary guidelines for a number of critical micronutrients, including vitamins A, D, E, 326 
pantothenic acid, folate, calcium, magnesium, potassium, and sodium. Vitamin D, 327 
calcium, potassium, and vitamin E were consumed in the lowest amounts, while sodium 328 
intake was exceedingly excessive.   329 
HIV-infected youth also had poorer micro- and macronutrient intake compared to 330 
healthy controls despite similarities in caloric intake. Proper nutrient intake is vital for 331 
optimal health in the HIV-infected population, as many micronutrients have been 332 
associated with diseases known to be increased in this population.  For example, HIV-333 
infected individuals are at an increased risk of CVD (2, 22, 30-31, 42-43).  Low serum 334 
vitamin D concentrations are associated with CVD risk factors in children and adults, in 335 
both the HIV-infected and HIV-uninfected populations (42-45).  Furthermore, consuming 336 
recommended amounts of potassium and sodium can help regulate blood pressure, 337 
another important factor in reducing CVD risk (26). 338 
Importantly, in our cohort of HIV-infected youth, we did observe a greater 339 
prevalence of dyslipidemia and significantly higher mean TG and significantly lower 340 
HDL-C than healthy controls.  Moreover, the HIV-infected youth in this study had a 341 
percent total fat, trans fat, and saturated fat intake from kilocalories that exceeded 342 
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recommendations, and fiber intake was less than recommendations in all but one subject.  343 
Fat and fiber intake aberrations have been associated with CVD risk in the general adult 344 
population.  For example, limiting dietary intake of saturated and trans fat is associated 345 
with a lower risk of CVD, mostly due to its positive effects on LDL-C (26).  Increased 346 
dietary fiber, both insoluble and soluble, has been linked with lower CVD risk and 347 
decreased progression to CVD in high-risk adults (26).    348 
Adult HIV studies have also shown associations between trans fat intake and 349 
serum TG levels (24), as well as between percent calories from fat and serum TC and TG 350 
(46).  Despite these findings previously found in adults, there were few meaningful 351 
associations between nutrient intake and lipid profiles in our cohort of HIV-infected 352 
youth.  These associations have not been previously studied in HIV-infected youth, and 353 
thus, nutrient intake may not have the same relationship to serum lipid levels as found in 354 
adults.  Alternatively, inadequate power and/or confounding factors may have played a 355 
role.  These relationships should be analyzed more systematically in future studies, given 356 
the high prevalence of dyslipidemia and high fat intake within this population.   357 
Importantly, appropriate micronutrient levels may contribute to improved immune 358 
status and survival in HIV-infected individuals (7, 8, 10-15, 47-49).  For instance, Baum 359 
and colleagues found that as serum vitamin A, B12, and zinc status improved, CD4+ cell 360 
counts increased in HIV-infected adult males (12).  This association between 361 
micronutrient sufficiency and HIV disease status has been repeated in other studies (5, 362 
12, 14-15), despite some conflicting data which investigated micronutrient intake (38).  363 
Notably, Steenkamp, et al showed that in ART-naïve children with abnormally low 364 
serum levels of zinc and vitamin A had significantly lower CD4+ cell counts and higher 365 
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HIV-1 RNA levels (5).   Decreased vitamin D concentrations have also been associated 366 
with increased mortality and HIV disease progression among several HIV-infected 367 
populations, including in children born to HIV-infected woman with vitamin D 368 
deficiency (48-49).   Similarly, vitamin E is important for immune function and is a 369 
potent antioxidant, which may be particularly important in HIV-infected individuals who 370 
have increased oxidative stress (6, 38).  371 
In our current study, we found some notable correlations between nutrient intake 372 
and variables used to assess HIV disease status. Vitamin A intake was positively 373 
correlated with nadir CD4+ cell count, and zinc, riboflavin, and magnesium intake were 374 
positively associated with current CD4+ cell count. In subjects not on ART and with 375 
uncontrolled viremia,  CD4+ cell count was not significantly correlated with zinc, niacin 376 
or vitamin A intake, as was shown in a previous studies (10, 15), but HIV-1 RNA was 377 
negatively correlated with dietary protein intake. This may suggest that HIV-infected 378 
individuals, especially when their viremia is not suppressed with ART, may be in an 379 
increased metabolic state, requiring additional protein. Studies showing a higher rate of 380 
protein oxidation in HIV-infected children corroborate this finding (34).  381 
Total intake of kilocalories was negatively correlated with current and nadir 382 
CD4+ cell counts, which may suggest that individuals with more advanced HIV disease 383 
(i.e. with a lower CD4 count and lower CD4 nadir) require a higher amount of calories 384 
compared to individuals with higher CD4 counts. This is consistent with the 385 
aforementioned findings suggesting that individuals not on ART with uncontrolled 386 
viremia may have not only greater protein needs, but  increased kilocalorie intake overall.  387 
When an individual’s immune system is highly immunocompromised and overwhelmed 388 
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with viremia, this may help to preserve immune function and/or allow a faster immune 389 
reconstitution once ART is initiated.  Previous studies evaluating caloric intake did not 390 
find any associations between CD4 category and progression to AIDS (15), or mortality 391 
(10).  However, these previous adult studies used semi-quantitative food frequency 392 
questionnaires, instead of the IOM’s recommendation to use at least two, 24-hour recalls 393 
on nonconsecutive days to assess usual intake (39), and were also done in the pre-ART 394 
era.  Thus, further investigation is warranted to determine total kilocalorie and protein 395 
needs at various clinical and virological stages of disease in HIV-infected youth.  In HIV-396 
infected adults, medical nutrition therapy has been shown to improve immune status, 397 
progression of HIV, and risk of mortality (21).   398 
Despite the important findings in our study, there were several limitations, 399 
including a cross-sectional design which cannot prove causality, a relatively small control 400 
group, and a wide-age range among our subject population.  In addition, while the IOM 401 
recommends using 24-hour recalls to determine nutrient intake (39), they do have 402 
drawbacks.   Due to their recall nature, there was likely over- or under-reporting of food 403 
intake.  We tried to account for this by omitting recalls that were clear outliers. 404 
Regardless, 24-hour dietary recalls still remain the best method for adequately assessing 405 
diet and making comparisons to DRIs (39).  Similarly, we are assuming that dietary 406 
intake is correlated with serum levels, and this may not be the case.  However, in studies 407 
investigating HIV-infected adults, correlations were found between serum concentrations 408 
and dietary intake of B12 (14), vitamin A, and zinc (12).  Additional studies are needed 409 
to determine whether nutrient intake data correlate with serum nutrient concentrations in 410 
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our current study population, and whether the serum nutrient status has an impact on 411 
immune status and HIV progression in HIV-infected youth.   412 
Our study was comprised of 95% African Americans, which limits our ability to 413 
generalize the results.  However, this race is particularly sensitive to the effects of these 414 
key nutrients on blood pressure and cardiovascular problems and may benefit the most 415 
from improving their nutrient intake based on these results (26). Finally, due to the large 416 
number of variables that were tested in univariate fashion, there was a risk of Type I 417 
errors.  However, these exploratory data provide a substrate from which to design future 418 
longitudinal, randomized-controlled trials. 419 
Nevertheless, this study offers insight into the diet of this vulnerable population 420 
and possible associations with HIV-related variables and chronic complication risk.  The 421 
important point is the high prevalence of suboptimal nutrient intake among HIV-infected 422 
children and young adults, which could have a serious impact on their long-term 423 
morbidity and mortality.   424 
These results are novel as few studies have evaluated nutrient intake in HIV-infected 425 
youth, and none has used 24-hour food intake recall data compared to the current micro- 426 
and macronutrient RDAs, which are the gold standards according to WHO and IOM (9, 427 
39).  Diet is a modifiable factor, and providing nutrition counseling early on in the 428 
disease process is likely to optimize health and improve long-term outcomes.  429 
Longitudinal, randomized-controlled trials are also needed not only to determine the 430 
impact of nutrition counseling on the nutrient status of HIV-infected youth, but to better 431 
define their actual intake requirements necessary to attenuate risk of chronic 432 
complications, such as CVD, and minimize disease progression.   433 
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Table 1. Subject Characteristics 607 
Mean ± SD or no. (%) 
 
HIV+ (n=175) Controls (n=43) P-value 
Age (Years) 17.44 ± 4.79 17.26 ± 6.14 0.688 
Race Black 166 (94.9%) 39 (90.7%) 0.183 
 White 6 (3.4%) 4 (9.3%) 
Latino 3 (1.7%) 0 (0%) 
Gender Male 94 (53.7%) 24 (55.8%) 0.804 
 Female 81 (46.3%) 19 (44.2%) 
Body Mass Index (kg/m2) 22.53 ± 5.72 22.16 ±5.17 0.813 
Waist-to-Hip Ratio 0.85 ± 0.08 0.83 ±0.07 0.124 
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Total Cholesterol (mg/dL) 155.29 ±38.929 150.67 ± 31.471 0.473 
LDL-Cholesterol (mg/dL) 94.66 ± 26.217 87.86 ± 28.779 0.138 
HDL-Cholesterol (mg/dL) 44.1 ± 15.923 51.16 ± 13.009 0.001 
Triglycerides (mg/dL) 84.35 ± 53.8 58.56 ± 23.757 0.001 
Currently on ART 119 (68%)   
ART-naïve 25 (14%)   
Perinatally-infected 113 (64%)   
Time from HIV diagnosis 
(years) 
10.9 ± 10.4   
CD4+ cell count (cells/mm3) 499 ± 361   
CD4+ cell count %  26.3 ±  12.1   
CD4+ cell count nadir 
(cells/mm3) 
291 ± 267   
∆CD4 (nadir-current) cell 
count (N=156) 
208 ± 255   
HIV-1 RNA <1000 copies/mL  101 (58%)    
Cumulative NRTI use 
(months)  
74.3 ±  65.2   
Cumulative PI use (months) 53.3 ±  54.5   
 
ART, antiretroviral therapy; NRTI, nucleoside/nucleotide analogue reverse transcriptase 
inhibitor; PI, protease inhibitor 
 608 
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Table 2. Mean % Dietary Reference Intakes 
 HIV-Infected (N=175) Controls (N=43) 
 Mean (± SD) 
Intake that Met 
DRI 
Mean (± SD) 
Intake That Did 
Not Meet DRI2 
Mean (± SD) 
Intake That Met 
DRI 
Mean (± SD) 
Intake That Did 
Not Meet DRI2 
 MICRONUTRIENTS 
Vitamin A -- 77.6% ± 120 -- 96.8% ± 75.0 
Vitamin D -- 27.0% ± 21.3 -- 36.0% ± 31.8 
Vitamin E -- 54.1% ± 33.7 -- 64.6% ± 27.9 
Vitamin K1 115.0% ± 120.9 -- 152.7% ± 146.0 -- 
Vitamin C 127.8% ± 109.4 -- 170.4% ± 110.8 -- 
Thiamin 145.3% ± 53.6 -- 170.8% ± 79.8 -- 
Riboflavin 154.5% ± 69.3 -- 196.4% ± 101.4 -- 
Niacin 259.7% ± 84.2 -- 285.4% ± 90.3 -- 
Pantothenic 
Acid 1 
-- 87.5% ± 38.2 106.1% ± 54.8 -- 
B-6 143.0% ± 58.8 -- 162.2% ± 64.8 -- 
Folate -- 96.8% ± 48.3 114.1% ± 54.4 -- 
B-12 208.4% ± 327.8 -- 225.3% ± 178.0 -- 
Calcium -- 57.6% ± 27.2 -- 69.5% ± 30.7 
Phosphorus 117.1% ± 53.5 -- 137.1% ± 58.6 -- 
Magnesium -- 63.7% ± 30.4 -- 80.2% ± 40.4  
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Manganese
1
 
114.8% ± 53.6 -- 133.0% ± 48.9 -- 
Iron 126.6% ± 69.7 -- 131.2% ± 66.8 -- 
Zinc 108.3% ± 46.9 -- 111.7% ± 41.6 -- 
Copper 133.7% ± 174.0 -- 151.9% ± 95.6 -- 
Selenium 206.6% ± 77.5 -- 228.4% ± 85.8 -- 
Sodium 1 -- 236.3% ± 83.1 -- 247.2% ± 74.3 
Potassium 1 -- 39.5% ± 14.1 -- 45.0% ± 12.7 
 
 MACRONUTRIENTS (% of total kilocalories) 
 Mean (± SD)  
Intake 
Within AMDR 
Mean (± SD)  
Intake 
Exceeds AMDR 
Mean (± SD)  
Intake 
Within AMDR 
Mean (± SD)  
Intake Exceeds 
AMDR 
Fat  -- 36.0% ± 5.73 33.8% ± 5.1 -- 
CHO  48.2% ± 7.0 -- 51.0% ± 5.6 -- 
Protein 15.7% ± 3.6 -- 14.9% ± 2.6 -- 
 
 
 
 
 
AHA RECOMMENDATIONS4 
 Mean % (± SD) of AHA recommended intake 
 Met  Did not meet 2 Met  Did not meet 2  
Saturated 
fat  
-- 165.0% ± 32.8 -- 158.8% ± 31.1 
Trans- fat  -- 145.1% ± 55.3 -- 115.0% ± 57.1 
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Cholesterol  85.0% ± 45.0 -- 87.7% ± 43.6 -- 
Fiber  -- 43.3% ± 13.7 -- 48.8% ± 15.7 
1
 Micronutrient with adequate intake (AI); micronutrients without superscript have 
recommended dietary allowance (RDA) 
2Significantly suboptimal intake with P  <0.001 
3Significantly suboptimal intake with P <0.05 
4AHA recommendations: Saturated fat = 7% of kcals; trans-fat = 1% of kcals; cholesterol = 
300mg/day; fiber = 14g/1000kcal 
AHA, American Heart Association; AMDR, acceptable macronutrient distribution range; 
CHO, carbohydrate;  DRI, dietary reference intake 
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Table 3. Associations between nutrient intake and HIV-related factors  
 Age BMI Current CD4+ Nadir CD4+ 
 r P r P r P r P 
Calories 0.152 0.003 -- -- -0.116 0.024 -0.105 0.041 
Phosphorus 0.253 <0.001 -- -- -- -- -- -- 
Sodium 0.133 0.027 -- -- -- -- -- -- 
Fat 0.122 0.017 -- -- -- -- -- -- 
Vitamin A -- -- -0.135 0.008 -- -- 0.102 0.047 
Vitamin D -- -- -0.108 0.034 -- -- -- -- 
Vitamin E -- -- -0.179 <0.001 -- -- -- -- 
Riboflavin -- -- -0.201 <0.001 0.120 0.019 0.1291 0.0331 
Thiamin -- -- -0.184 <0.001 -- -- -- -- 
Niacin -- -- -0.162 0.002 -- -- -- -- 
Pantothenic 
Acid 
-- -- -0.146 0.004 -- -- -- -- 
Vitamin B6 -- -- -0.173 0.001 -- -- -- -- 
Folate -- -- -0.190 <0.001 -- -- -- -- 
Vitamin 
B12 
-- -- -0.129 0.012 -- -- 0.1221 0.0441 
Magnesium 
-- -- -0.229 <0.001 0.141 
0.1401 
 
0.006 
0.0201 
-- -- 
Iron -- -- -0.122 0.017 -- -- -- -- 
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Zinc 
-- -- -0.179 <0.001 0.128 
0.1881 
0.013 
0.0501 
-- -- 
Copper -- -- -0.210 <0.001 -- -- -- -- 
Potassium -- -- -0.110 0.032 -- -- -- -- 
Selenium -- -- -0.163 0.001 -- -- -- -- 
 622 
 623 
 624 
 625 
 626 
 627 
 628 
 629 
 630 
 631 
 632 
r=Pearson’s correlation coefficient 
1
 Includes only HIV+ subjects currently on antiretroviral medication (N=119) 
No significant correlations were found between nutrients and those variables without numbers reported in 
the table, or for those nutrients not listed in the table.  
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FIGURE LEGEND 668 
 669 
Figure 1. HIV+ Micronutrient Intake Deficiencies: Differences Between Groups in Mean 670 
% DRI intake.  671 
 672 
Figure 2. Differences Between Mean % Intake of AHA recommendation.  673 
* denotes a significant difference from AHA recommendations with a P-value < 0.001 674 
+ denotes significantly within AHA recommendations with P-value <0.001 675 
ŧ  denotes significant difference from AHA recommendations with a P-value < 0.05 676 
P-values above the bars show significant differences between HIV+ and Controls 677 
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